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mixĤ∆  Heat of Mixing
ˆ
solH∆  Heat of Dissolution per Mole
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 Incorporation of solvent molecules into the crystal structure of an organic 
compound has strong effects on the solvate’s chemical and physical properties; and 
hence, pharmacokinetics.  Therefore, a study on pseudopolymorphic transitions and the 
ability of solvents to form pseudopolymorphs with pharmaceutical compounds is 
important for the pharmaceutical industries. 
 The main goals of this study were to provide quantitative descriptions of the 
crystallization and solid-state transformation of pseudopolymorphs of sodium naproxen 
in mixed alcohol-water solvents.  Furthermore, organic alcohol solvates of sodium 
naproxen were discovered, and characterized qualitatively and quantitatively. 
 Several pseudopolymorphic forms of sodium naproxen were crystallized from 
methanol-water and ethanol-water solutions, including hydrated and alcohol-solvated 
forms.  Results showed that the transitions of the pseudopolymorphic forms occurred at 
temperatures that depended upon the solvent concentration.  Results also revealed that 
water activity was a controlling factor for the transitions because regardless of which 
alcohol solvent mixture was used, the water activity was the same for similar transitions. 
 A methanol-solvated form of sodium naproxen was discovered and fully 
characterized using a variety of analytical techniques.  The methanol solvate was 
crystallized from pure methanol at 10°C and was determined to be in a one to one ratio of 
sodium naproxen to methanol.  For further analysis, a single crystal study of crystals 
obtained by slowly evaporating methanol at approximately 4°C was performed and 
revealed a solvate with a two to three ratio of sodium naproxen to methanol.  The 1.5 
solvate was shown to not be representative of the entire sample, but still provided insight 
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into the bonding of the methanol solvent in sodium naproxen.  Hydrogen bonding was 
determined to be the main force in solvation, along with Na-O coordination between 
methanol and sodium naproxen. 
The heats of solution for each pseudopolymorph were estimated by fitting the 
solubility data with the van’t Hoff equation.  The stability of hydrated forms over 
solvated forms at higher temperatures was proven for enantiotropic systems from a 
thermodynamic cycle. 
 Additionally, the ability of sodium naproxen to solvate with other alcohol solvents 
was explored, specifically looking at comparisons between ethanol, 1-propanol, 2-
propanol, 1-butanol, and isobutanol solvents.  It was shown that as the size and/or 
branching of the alcohol increased the ability to solvate decreased in relation to the molar 
amount of the alcohol present in the crystal structure.  Additionally larger, branched 
alcohols required more energy to desolvate based on the energy per mole of alcohol.  
This is related to the fact that these solvates had a smaller amount of alcohol present in 
the solvate; and hence, had strong bonding with the sodium naproxen molecule. 
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CHAPTER 1  
INTRODUCTION 
 
Incorporation of solvent into the crystal structure of organic compounds can lead 
to changes in both physical and chemical properties.  These solvates often have different 
unit cells leading to changes in physical properties, such as density, solubility, 
bioavailability, and dissolution rate.  The changes in physical properties are similar to 
those seen in polymorphs (chemical species with the same molecular formula, but 
different crystal structures); hence solvates are often termed pseudopolymorphs 
(Kuhnertb and Gasser, 1971).  In the present student, a number of pseudopolymorphic 
forms of sodium naproxen were examined.  This includes the previously studied 
anhydrous, monohydrated, and dihydrated forms, as well as, newly discovered organic 
alcohol-solvated forms.  Organic alcohol solvents were studied because they are often 
used in manufacturing processes for organic compounds, such as sodium naproxen.  The 
alcohol solvates examined include those of methanol, ethanol, propanol, and butanol 
incorporated in sodium naproxen. 
Crystalline solvates and hydrates play an important role in the pharmaceutical 
industry (Morris, 1999).  The formation of pseudopolymorphs of pharmaceuticals can be 
of great significance because changes in the physical properties of the crystal can affect 
the safety and efficacy of a drug.  Bioavailability and/or physiochemical stability of 
pseudopolymorphs can raise issues during the development of new pharmaceuticals.  For 
example, hydrated compounds can convert to amorphous forms upon dehydration.  
Cephradine dihydrate dehydrates to become amorphous and undergoes subsequent 
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oxidation (Florey, 1973).  Dihydrophenylalanine anhydrate crystallized from ether is 
stable to oxidation; however, the dihydrated form oxidizes in air producing 70% 
phenylalanine in ten minutes (Byrn and Lin, 1976; Ressler, 1972).  Also, stability and 
instability of various solvates play important roles in pharmaceutical development.  For 
example, aripiprazole is known to exist in five reproducible pseudopolymorphic forms, 
but only four of them are stable.  The dichloromethane solvate form is reproducible but 
highly unstable.  Additionally, a number of other solvates disclosed in patent literature 
have been seen but are not reliably reproducible (Braun et al., 2009).  Therefore, a 
comprehensive understanding of pseudopolymorphic formation is important in 
developing reliable and stable pharmaceuticals. 
Furthermore, technical and industrial uses of solvates concern issues such as 
purification, preparation of a specific polymorphs with high chemical and physical purity, 
or particle size control due to the fact that desolvation of stoichiometric solvates often 
leads to products with a small and homogenous particle size distribution (Griesser, 2006).  
Purification of dirithromycin, a macrolide antibiotic, is achieved by the formation of the 
acetone solvate followed by heating in water to convert it to a nosolvated, stable 
polymorphic form (Wirth and Stephenson, 1997).  Both prilocaine hydrochloride and 
zanoterone exhibit specific polymorphic forms only via transformation from a solvated 
form (Schmidt et al., 2004; Rocco et al., 1995).  Solvent adducts can often crystallize 
more easily than solvent-free molecules, because of more efficient packing achieved with 
the addition of the solvent molecules, as is the case for R-cinacalcet  hydrocholoride, a 
therapeutic agent marketed as Sensipar®, Mimpara®, and Parareg® (Braum et al., 2008).  
As illustrated, formation of solvates can play a crucial role in pharmaceutical 
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development due to the fact that they can be the only pathway to certain polymorphic 
forms or they can reduce the need for additional processing steps, such as milling. 
Formation of pseudopolymorphs is affected by a number of variables such as 
temperature, pressure, and solvent choice; thus, changing operating variables during 
crystallization may result in changes to pseudopolymorphic forms or the discovery of 
new forms.  One of the most unusual cases can be seen in the polymorph Ritonavir 
(Bauer et al., 2001).  Form I of Ritonavir was the only form seen during the development 
stages of the pharmaceutical, but during manufacturing a second form (Form II), which 
had a significant lower solubility, was discovered.  Form II was both unusually stable and 
difficult to crystallize, but did hinder production.  Recognition of the variables that can 
affect polymorphic and pseudopolymorphic transitions is important in preventing 
unwanted changes to pharmaceuticals. 
The present study was motivated by pseudopolymorphic transitions seen in 
varying solvent concentrations of sodium naproxen and the thermodynamic reasons for 
these transitions.  It was previously shown that sodium naproxen transitions from a 
dihydrate to an anhydrate in pure water solutions with changing temperature, and that the 
addition of methanol to the solvent at a 64 mol% concentration produces a transition from 
a dihydrated form to a monohydrated form (Kim and Rousseau, 2005).  Since some work 
had begun on mixed-solvent systems and pseudopolymorphic transitions of sodium 
naproxen prior to this work, one aim was to determine what thermodynamic factors 
controlled pseudopolymorphic transitions in these mixed-solvent systems. Additionally, 
understanding how changes in solvent concentrations affected these pseudopolymorphic 
transitions was another aim.  
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In the present work, two main areas were addressed; these were derived from the 
above mentioned motivations and goals: (1) solvent-mediated transitions of 
pseudopolymorphic forms of sodium naproxen in mixed alcohol-water systems, and (2) 
the ability of organic alcohols to form solvates with sodium naproxen based on the 
carbon chain length and branching.  An outline of the remaining chapters is presented 
below: 
◊ Chapter 2: basic background information is discussed that relates to the 
information presented in this work. 
◊ Chapter 3: solubility of anhydrous sodium naproxen in methanol-water and 
ethanol-water solvents was studied, along with the observation of changes in 
pseudopolymorphic forms across the studied temperature range.  Methanol 
created a general salting-in effect, while ethanol solutions created a salting-out 
effect. 
◊ Chapter 4: determination of the actual transition point for the 
pseudopolymorphic forms was determined based on van’t Hoff plots of 
solubility and temperature.  The data was also manipulated to determine the 
role of water and alcohol activity in determining when a transition would 
occur in reference to changes in the alcohol solvent used.  It was found that 
water activity played an effective role in determining pseudopolymorphic 
transition points, while alcohol activity did not.  This was explained by the 
equation for the equilibrium constant of the transition and its squared 
dependence on the activity of water. 
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◊ Chapter 5: the stability of dihydrated versus alcohol solvated sodium naproxen 
in mixed solvent systems, based on the heats of dissolution of the 
pseudopolymorphs, is analyzed using slight modifications of a previously 
developed method.  The analysis gives validation to the fact that the 
dihydrated form of sodium naproxen is seen at higher temperatures than the 
alcohol solvated forms of sodium naproxen, as presented in chapter 4.  It can 
also provide an estimate of the heat of dissolution of pseudopolymorphs in 
mixed solvent systems. 
◊ Chapter 6:  a novel methanol solvate form of sodium naproxen was 
characterized using a variety of analytical techniques including thermal 
gravimetric analysis, differential scanning calorimetry, proton nuclear 
magnetic resonance, polarized light microscopy, and powder x-ray diffraction. 
◊ Chapter 7: the crystal structure of a methanol solvated form of sodium 
naproxen is discussed based on single crystal x-ray diffraction techniques.  
Comparison is made between its crystal structure and the other solved crystal 
structures of pseudopolymorphs of sodium naproxen. Additionally, this 
methanol solvate is compared to the methanol solvate discussed in chapter 6. 
◊ Chapter 8: other organic alcohol solvates are discussed in terms of their 
similarities and differences to the hydrated forms of sodium naproxen.  These 
solvates were analyzed by thermal gravimetric analysis, differential scanning 
calorimetry, proton nuclear magnetic resonance, polarized light microscopy, 
and powder x-ray diffraction.  Desolvation endotherms were compared to the 
size and bulkiness of the organic alcohols present in the crystal structure. 
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◊ Chapter 9: conclusions and recommendations for further work in this area. 
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CHAPTER 2  
BACKGROUND 
 
This chapter provides a basic background for the work being presented in this 
thesis. 
2.1 Crystallography 
2.1.1 Lattice and Unit Cells of Crystal Systems 
A true solid crystal is comprised of a rigid lattice of molecules, atoms, or ions, the 
locations of which are characteristic of the substance (Mullin, 2004).  Ideally a crystal is 
constructed using identical structural units that repeat in space.  A three-dimensional 
array is referred to as a lattice (see Figure 2.1).  It is purely a mathematical abstraction 
and refers to the fact that a three-dimensional grid of lines can be used to connect the 
lattice points.  The lattice points can represent a single atom, as with a monatomic 
element, or can contain one or more molecules, as with an organic species.  The crystal 
structure is only formed when the fundamental unit is attached identically through the 
lattice and extended along each crystal axis through translational repetition (Brittain and 








The axes which form the smallest parallelepiped, repeated block is termed a unit 
cell.  The unit cell can be described by six scalars, a, b, c, α, β, and γ, as seen in Figure 
2.2.  By elementary vector analysis, the volume of the unit cell is defined by 
cV a b c= × ⋅                                                                                           (2-1) 
Several kinds of unit cells are possible by varying the six scalars.  For example, if a = b = 
c and α = β = γ, a cubic unit cell exists, such as with iron and chromium.  Only seven unit 




















Table 2.1. Seven crystal classes based on the fundamental unit cells. 
Crystal Class Relationship betweenCell Edges 
Relationship between 
Cell Angles 
Cubic a = b =  c α = β = γ = 90° 
Tetragonal a = b ≠  c α = β = γ = 90° 
Orthorhombic a  ≠ b ≠ c α = β = γ = 90° 
Monoclinic a  ≠ b ≠ c α = γ = 90° β ≠ 90° 
Triclinic a  ≠ b ≠ c α ≠ β  ≠ γ  ≠ 90° 
Hexagonal a = b ≠ c α = β = 90° γ = 120° 




2.1.2 Space Groups 
Although there are seven different crystal systems, there are more possible 
arrangements of the points that do not violate the lattice constraints.  Auguste Bravais 
postulated in 1949 that there were only 14 possible basic types of lattices that could fit 
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within the constraints of the seven crystal systems.  These fourteen lattices are shown in 
Figure 2.3.  
Crystal structures can be carried into themselves by various point symmetry 
operations.  These symmetry operations are defined as an operation that moves the 
system into a new configuration that is equivalent to and indistinguishable from the 
original one.  There are seven symmetry operations: identity, reflection, inversion, proper 
rotation, improper rotation, screw operation, and plane glide.  Identity leaves the system 
unchanged and in an orientation identical to the original.  The second symmetry operation 
is reflection through a plane.  This changes the sign of the coordinates perpendicular to 
the plane while leaving the coordinates parallel to the plane unchanged.  Inversion 
through a point changes the sign of all coordinates of the lattice points.  Proper rotation 
is defined as a simple rotation about an axis.  Finally, improper rotation is merely a 
proper rotation followed by an inversion.  These first five operations are described as 
macroscopic operations.  Performing these operations on each of the 7 crystal systems 









TrigonalMonoclinic TriclinicHexagonal  
Figure 2.3.  The fourteen Bravais lattices (Mullin, 2004). 
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The remaining two symmetry operations are termed microscopic operations.  The 
screw operation couples a proper rotation with a translation parallel to the axis of 
rotation.  A glide plane operation combines a reflection with a translations operation.  
Combining the 14 Bravais Lattices with the 32 point groups and performing these 
remaining two operations leads the 230 space groups.  The relationship between the 7 























Figure 2.4. Schematic of the relationship between the 7 crystal systems, 14 Bravais 




2.1.3 Plane Spacing 
Wilhelm Röntgen discovered x-rays in 1895 and seventeen years later, Max von 
Laue suggested that they may diffract when passed through a crystal.  He realized that 
their wavelengths are comparable to the separation of lattice planes.  Under von Laue, 
Walter Friedrich and Paul Knipping confirmed this (Atkins, 1998).  If one regards a 
lattice plane as a mirror and a crystal as merely stacks of reflecting lattice planes of 
separation d, one can calculate the angle the crystal must make with the incoming beam 
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of x-rays for constructive interference.  W.L. Bragg was able to express the necessary 
conditions for diffraction in a simple mathematical form known as Bragg’s law: 
hkl2d sinθλ =                                                                                         (2-2), 
where λ is the wavelength of the x-ray, dhkl is the distance between the two lattice planes 
of the crystal, and θ is the angle of incidence.  Figure 2.5 shows the relationship between 














Braggs’ equation gives an easy way to understand powder x-ray diffraction.  
Powder x-ray diffraction data has information on peak positions and intensities.  Peak 
positions can be related to unit cell constants and intensities to the contents of the unit 
cell.  Interplanar spacing is a function of the cell constants.  Therefore, if the cell 
constants are known for a crystalline compound, peak positions can be obtained from the 
Bragg equation (λ is dependent on the machine).  Reversing this process one would be 
able to determine cell parameters from powder x-ray diffraction patterns. 
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2.2 Solid-State Phases 
During crystallization and pharmaceutical formulation processing, a number of 
solid-state phases can occur. These can include polymorphs, solvates, desolvated 
solvates, and amorphous material. Polymorphs are defined as crystal species with the 
same chemical formula but different crystal structures.  Solvates are the incorporation of 
a solvent into the crystal structure.  Removal of the solvent creates desolvated forms of 
the solvates.  Amorphous materials have no long-range atomic order.  Figure 2.6 shows 
the possibilities for solid-state phases.  A reproducible production of the solid state 
demonstrates control over the manufacturing process of the pharmaceutical ingredient, 








Figure 2.6. Solid state phases (Brittain and Byrn, 1999). 
Solid-State Form  
Crystalline Amorphous 




2.2.1 Polymorphism and Pseudopolymorphism 
Many organic and inorganic pharmaceutical compounds can crystallize in two or 
more solid forms while having the same chemical composition.  These solid forms are 
referred to as polymorphs.  Due to their varying crystal structures, polymorphs have 
varying physical properties, such as solubility, hygroscopicity, dissolution rate, and 
compactability. 
Solvents are often used in the production of crystalline pharmaceutical species 
and during processing.  These solvents can become incorporated into the lattice of the 
crystal in a specific stoichiometric ratio, thus forming solvates or hydrates (also known as 
pseudopolymorphs) (Bechtloff et al., 2001).  The properties of pseudopolymorphs differ 
from those of the unsolvated species, which should not be surprising because their 
compositions are different. Accordingly, transformations among pseudopolymorphic 
forms often produce variations in physical properties such as density, solubility, 
dissolution rate, and bioavailability.  These changes in physical form can interrupt 
downstream processing during manufacturing.  Furthermore, the formation of 
pseudopolymorphs of pharmaceuticals can be of great importance because changes in the 
physical properties of the crystal can affect the safety and efficacy of a drug.  For 
example, some hydrated compounds may convert to an amorphous form upon 
dehydration and may become chemically labile.  Some examples of how 
pseudopolymorphism can affect the efficacy of a drug include cephradine dihydrate and 
ampicillin.  Cephradine upon dehydration becomes amorphous and then undergoes 
oxidation (Florey, 1973). Due to the aqueous solubility differences between the 
anhydrous and trihydrated form of ampicillin, blood serum concentrations of the 
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anhydrous form are higher and reach optimal levels earlier than the trihydrated form 
(Poole et al., 1968).  Thus, knowing the presence or existence of crystal 
pseudopolymorphs is of importance in developing robust, large-scale crystallization 
processes in the pharmaceutical industry and is becoming more important within the 
current regulatory climate.   
2.2.2 Types of Polymorphism 
There are two forms of polymorphism: packing polymorphism and 
conformational polymorphism (Brittain and Byrn, 1999).   
Packing polymorphism represents molecules that exist as a rigid group of atoms 
with definite symmetry that can be stacked differently to occupy the points of different 
lattices.  This form of polymorphism is readily available to compounds for which 
hydrogen bonding is important, and for which there exists multiple possibilities to 
achieve the necessary intramolecular and intermolecular interactions.  Figure 2.7 shows 
the three polymorphic forms of ethyl maltol (Brown et al., 1995).  Each polymorph has a 
different mode of hydrogen bonding; Form 1 contains nearly planar chains of molecules, 









Form 3  
Figure 2.7. Three polymorphic forms of ethyl maltol (Brown et al., 1995). 
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 Packing polymorphism usually represents different modes by which molecules in 
their most favorable conformational state are assembled into different solid structures.  
When different conformational states are possible, conformational polymorphism may 
result.  Conformations arise from rotation about single bonds, corresponding to potential 
energy minima.  The various conformations cannot differ too greatly in free energy 
content from the equilibrium structure of the molecule.  It is this proximity of molecular 
conformation energies that makes possible the existence of different molecular 
conformations in a single-crystal structure.  For example, lomeridine dihydrochloride has 
been reported to exist in two conformational polymorphic forms as shown in Figure 2.8 
(Hiramatsu et al., 1996).  Although the molecular conformations are similar for the two 
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2.2.3 Classification of Hydrates 
Water is small enough to fill many commonly occurring periodic “voids” formed 
when larger molecules are packed, and it interacts through hydrogen bonding to 
overcome energy barriers.  This characteristic gives rise to a series of water arrangements 
in crystal structures.  Table 2.2 lists the classification of crystalline hydrates.   
 
 
Table 2.2. Classification of crystalline hydrates (Morris, 1999). 
Class Description 
1 Isolated Lattice Sites 
2 Lattice Channels 
       -a Expanded Channels (Non-Stoichiometric) 
       -b Lattice Planes 
       -c Dehydrated Hydrates 




Isolated site hydrates represent hydrates where water molecules are isolated from 
each other and surrounded by intervening molecules of the host structure.  This means 
that water molecules on the surface of the crystal can be easily lost, but does not leave 
other water molecules accessible.  Similarly, there is no network of hydrogen bonding 
that solely involves water molecules on any axis through the crystals.  These types of 
hydrates should yield sharp DSC endotherms and a narrow TGA weight loss. 
Hydrates in the second class, lattice channel hydrates, contain water molecules 
that lie next to one another along an axis of the lattice forming “channels” through the 
crystal.  For TGA and DSC data, early onset of dehydration is present, followed by a 
broad water loss step.  This is due to the fact that dehydration begins at the “ends” of the 
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crystal and continues towards the center along the channels.  Additionally, some channel 
hydrates may take up additional moisture when exposed to high humidity, such as 
chromylin sodium (Cox et al., 1971).  Upon water addition, such hydrates may expand, 
which is why they are termed expanded channels.  Planar hydrates have the water 
molecules localized in a two-dimensional order or plane, hence the term lattice planes.  
Dehydrated hydrates dehydrate at relatively high partial pressures of water, or they 
dehydrate shortly after removal from the mother liquor.  The dehydration leaves an intact 
anhydrous structure similar to the hydrated structure but with a lower density. 
Ion associated hydrates contain metal ion coordinated water.  The metal-water 
interaction can be quite strong; hence, dehydration only takes place at very high 
temperatures.  In DSC and TGA thermograms, very sharp peaks corresponding to loss of 
the water bonded with the metal ions are expected at high temperatures. 
2.3 Solubility Behavior 
2.3.1 Polymorphs and Pseudopolymorphic Systems 
Polymorphs and pseudopolymorphs are classified as either monotropic or 
enantiotropic, depending on if one form can change reversibly to the other (Ostwald, 
1897).  For monotropic systems, as shown in Figure 2.9 (a), the transition temperature 
from Form I to Form II does not appear before the melting temperature; therefore, Form I 
cannot transform to Form II reversibly.    In Figure 2.9 (b), Form II is stable until a 
transition temperature is reached, here the two solubility curves meet and then Form I is 
stable above the transition temperature.  This is an example of an enantiotropic system; at 
the transition temperature, reversible transformation between the two forms exists.  By 
examining kinetic effects on thermodynamic properties of solubility, Figure 2.9 (c) is 
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established.  The dotted lines represent metastable behavior of the two forms.  If X 
identifies the initial conditions of the system and crystallization is allowed to occur 
isothermally, the Ostwald rule of stages suggests that, Form I, which is metastable, would 
crystallize first, and then reform into a stable Form II.  The Ostwald rule of stages states 
that an unstable system does not necessarily transfer to the most stable system, but 
instead transforms to the system that allows for the smallest loss of free energy (Prausnitz 


























































































































Figure 2.9. Solubility curves exhibiting (a) monotropy, (b) enantiotropy, and (c) 




Thermodynamic rules were also developed by Burger and Ramberger in 1979 to 
determine if two polymorphs were monotropes or enantiotropes.  These rules are 








Table 2.3.  Relative thermodynamic properties of monotropic and enantiotropic 
polymorphs (Burger and Ramberger, 1979). 
 
Monotropes Enantiotropes 
Form Itransition fusionT T>  Form Itransition fusionT T<  
Form I stable 
Form I: stable for transitionT T>  
Form II: stable for transitionT T<  
Transition Irreversible Transition Reversible 
Exothermic Transition of II  I Endothermic Transition of II  I 
Solubility I < Solubility II 
Solubility I > Solubility II for transitionT T<  
Solubility I < Solubility II for transitionT T>  




Intermolecular forces between solute and solvent are a strong influence on 
solubility (Prausnitz et al., 1999).  However, other factors besides the intermolecular 
forces between the solute and solvent can play a role in determining the solubility of the 
solute, e.g. solubility can also depend on the fugacity of the pure solid and the fugacity of 
the standard state to which the activity coefficient would refer. 
The solid-liquid equilibrium equation is 
( ) ( )pure solid solute in liquid solutionf f=                                                                   (2-3) 
or 
( ) solute solute solutepure solidf x fγ=                                                                       (2-4) 
where solutex  is the solubility (mole fraction) of the solute in the solvent, soluteγ  is the 
activity coefficient in the liquid-phase, and solutef  is the standard-state fugacity.  From the 








=                                                                                   (2-5) 
Thus the solubility of the solid depends on both the activity coefficient and the ratio of 
the two fugacities. 
The two fugacities are independent of the solvent; they depend only on the 
properties of the solute.  The standard-state fugacity is usually defined as the fugacity of 
the pure, subcooled liquid at the temperature of the solution and at some specific 
pressure.  The ratio of the fugacities is also related to the Gibbs energy change for the 
solute, as follows: 
( )
solute
a d pure solid
ln fg RT
f→
∆ =                                                                              (2-6) 
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∆ = ∆ − ∆                                                                                       (2-7) 
Using the thermodynamic cycle presented above (assuming the heat of mixing from b→c 
is zero) and the above equations, a general expression for solubility can be established, 
p pt t tf
solute t
1ln 1 1 ln
c cT T Th
x RT T R T R Tγ
∆ ∆∆ ⎛ ⎞ ⎛ ⎞= − − − +⎜ ⎟ ⎜ ⎟
⎝ ⎠ ⎝ ⎠
                         (2-8). 






= − +                                                                                (2-9). 
The first assumption is the difference between the triple-point temperature and the 
melting temperature is small, therefore differences in the enthalpies of fusion at these 
temperatures are taken to be small.  So one can substitute the melting temperature for the 
triple-point temperature and use the enthalpy of fusion at the melting temperature.  
Second, pc∆ , the differences in the heat capacity of the solute in its solid-state and its 
liquid-state, is relatively small.  Additionally as tT
T
 goes to one, tln T
T
 goes to t 1T
T
− .  
This allows the second and third terms of the equation on the right-hand side to be 
neglected.  Third, the solution is assumed to behave ideally, and γ  is taken to be one. 
To account for non-ideality of the solution, i.e. to eliminate one of the 
assumptions made in the van’t Hoff equation, the enthalpy of fusion can be replaced by 
the heat of solution, dĤ∆ , and the entropy of fusion by the entropy of solution, dŜ∆  







= − +                                                                            (2-10). 
van’t Hoff plots ( ln vs.1x T ) have been used to show discontinuities in solubility 
between pseudopolymorphs of enantiotropic pharmaceuticals, such as carbamazepine 
(Qu et al., 2006), and theophylline (Khanhari and Grant 1995).  Since each 
pseudopolymorph has distinct dH
∧
∆  and dS
∧
∆ values, a van’t Hoff plot should show 
distinct lines for each pseudopolymorph.  The point where the two lines crossed is 
referred to as the transition point. 
2.3.2 Salting-Out Effects 
A solution can be made supersaturated, with respect to a given solute, by the 
addition of a substance that reduces the solubility of the solute in the solvent.  In the 
pharmaceutical industry, the precipitation of organic substances from water-miscible 
organic solvents is controlled by the addition of water to the solution.  This is generally 
termed ‘watering-out’.  In contrast, the addition of a water-miscible organic solvent to an 
aqueous solution has been termed ‘drowning-out’, ‘quenching’, and ‘solventing-out’.  
The term ‘salting-out’ is generally used to encompass all of the above examples. 
Salting out has many advantages.  For example, highly concentrated initial 
solutions can be made by dissolving an impure crystalline material in a suitable solvent.  
If the solute is highly soluble in the solvent, dissolution may be affected at low 
temperatures which are advantageous for the processing of heat sensitive materials.  
Additionally, a slight dilution of the salting-out agent with the solvent can be beneficial 
in avoiding excessive nucleation in the regions of primary contacts. 
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There are four basic theories with regard to the salting-out/in effect as described 
by Long et al. (1951):  hydration theories, electrostatic theories, van der Waals forces, 
and an internal pressure concept.  Hydration theories stem from the idea that water 
molecules are removed from their solvent role due to “hydration” of the ions; that water 
dipoles are oriented in the hydration shell around an ion.  So there is a preferred 
orientation of water molecules toward a polar non-electrolyte, which means that ions of 
one sign should promote its solubility while those of the opposite sign should have an 
increased salting-out effect.  Although this theory does not explain variations in the 
effects of different salts on non-polar solutes, it does attempt to explain that local solvent 
structure should play a significant role. 
Electrostatic theories, which stem from Debye and McAulay, relate salt effects to 
the influence of non-electrolytes on the dielectric constant of the solvent.  The amount of 
work necessary to discharge the ions in the pure solvent and to recharge them in a 
solution containing the non-electrolyte yields the electrostatic contribution to the 
chemical potential of the neutral solute.  The solvent is simply treated as a continuous 
dielectric and only departures from non-ideality are considered.  For this theory, these 
departures arise from electrostatic interactions involving the ionic charges only and do 
not preclude the possibility that other types of forces may be important.  Partially due to 
this reason, the theories can not reasonably account for the variation in the effect of 
different electrolytes and even fails whenever there is a shift from salting-out to salting-in 
of a particular non-electrolyte. 
To expand upon the short range nature of the electrostatic interactions between an 
ion and a neutral molecule from the electrostatic theories, other short range forces, such 
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as dispersion forces, were considered.  It was suggested that van der Waals interactions 
may be responsible for salting in by large ions and by simply adding terms for the 
potential of dispersion forces to the electrostatic equations, these forces could be taken 
into consideration.  As a result, these theories were able to predict salting-in effects by 
large ions, but fail to indicate low salting-out effects, generally observed for lithium and 
hydrogen ions, and do not fit data for some non-electrolytes.  One reason for the failure 
was thought to be the lack of accounting for the water molecules displaced by the ions.  
Although the theories account for water molecules displaced by neutral solutes, there are 
no terms for similar displacements from ions.   
The internal pressure concept relates salt effects to other properties of the salt 
solutions themselves.  A connection can be seen between the order of increasing volume 
contractions on dissolving salts and the order of increasing salting out of certain solutes.  
A similar correlation can be seen between salt effects and the relative effects of salts in 
decreasing the compressibility of the solution.  By considering that neutral molecules 
merely take up space and hence modify the ion-water interaction, the free energy transfer 
of non-polar non-electrolyte from pure water to the salt solution can be calculated and a 
limiting law for sk , the salting out parameter, can be obtained.  Furthermore, the 
parameter can also be expressed in terms of eP , the “effective pressure” exerted by salts in 
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Where sC  is the molar concentration of the electrolyte, iV  is the partial molar volume of 
the non-electrolyte at infinite dilution, R  is the gas constant, T  is absolute temperature, 
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sV  is the molar volume of the pure electrolyte, sV  is the partial molar volume of the pure 
electrolyte at infinite dilution, and β  is the compressibility of pure water.  The 
expression corresponds to the idea that the non-ideal free energy of transfer relates 
to e iPV .  According to this final concept, salting-out and salting-in of a non-polar solute is 
determined by the extent to which the solvent medium is compressed or loosened when 
ions are present. 
 None of the theories provide a complete picture of salting-in and salting-out 
effects for every system, but together they create a comprehensive overview of the 
properties necessary to consider when looking at a particular system. 
2.4 Naproxen and Sodium Naproxen 
Naproxen1 was introduced into the market in 1976 by Syntex and is a nonsteroidal 
anti-inflammatory drug (NSAID); sodium naproxen (the sodium salt of naproxen) was 
introduced in 1980 (Harrington and Lodewijk, 1997).  Naproxen is used for the reduction 
of moderate to severe pain, fever, inflammation, and stiffness caused by conditions such 
as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, menstrual cramps, and the 
treatment of dysmenorrheal (Chen et al., 1992).  Both naproxen and sodium naproxen are 
available in prescription strength; sodium naproxen is also available as an over-the-
counter medication as of 1994.  
The first large scale production of naproxen was in 1970 and produced 500 kg of 
material.  The synthesis began with a Friedel-Craft acylation of 2-methoxynaphthalene 
(nerolin) to produce 2-acetyl-6-methoxynaphthalene (Harrington and Lodewijk, 1997).  
                                                 
1 (S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid 
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This was then converted, using a Willgerodt reaction, to naphthylacetic acid.  An α-
methylation will yield the D, L-acid, which is then resolved using cinchonidine. 
Sodium Naproxen has a much higher solubility in water than naproxen, thus 
making its applicability as a pharmaceutical compound greater than its acid free form. 
(Kim et al., 2004)  Producing crystals with a chiral purity of 99% or more and 
significantly larger than 70 µm was a major improvement in 1999 (Phan and Young, 
1999; Phan and Allen, 1999).  Phan et al. showed that chiral purity of 99% or more could 
be achieved while neutralizing (s)-2-(6-methoxy-2-naphthyl)propionic acid having a 
chiral purity of less than 99% (at least about 82%, but below 99%) with less than 
stoichiometric amount of aqueous sodium hydroxide, then, by removing the water either 
with a suitable organic solvent or simple distillation.  Crystal size can be improved by a 
process that forms a solids-free liquid mixture of naproxen, water, an organic solvent, and 
at least one water-soluble inorganic basic sodium compound in an amount proportioned 
to neutralize from about 50% to 97% of the acid.  Water removal leaves the monohydrate 
form of sodium naproxen with an average particle size of 120 µm and a chiral purity of at 
least 98% (S)-enantiomer.  This process has the advantage of producing larger crystals 
which can reduce centrifugation cycle time and simplifying product handling during 
other operations, such as drying, flowing, screening, or tableting.  This procedure does 
require an addition dehydration step to produce the commercially available anhydrous 
sodium naproxen from the monohydrated form.  The optically pure (S)-(+)-sodium 










 The crystal structure of sodium naproxen was solved my Kim et al. (2004) to 
show the crystal parameters illustrated in Table 2.4. 
 
 
Table 2.4. Unit cell parameters of anhydrous sodium naproxen. 
Parameter Value 
Crystal Class Monoclinic 
Space Group P21 
Crystal Habit Prism, colorless
Unit Cell Lengths
a = 9.969 Å 
b = 5.9346 Å 
c = 20.823 Å 
Unit Cell Angles 
α = 90° 
β = 102.025° 
γ = 90° 




2.4.1 Hydrates of Sodium Naproxen 
Currently, sodium naproxen has been shown to exhibit 4 hydrate forms; 
anhydrous, monohydrate, dihydrate and tetrahydrate.  Each of the hydrates has been 
thoroughly characterized in previous research and the conditions leading to transitions of 
these hydrates are illustrated in Figure 2.12 (Kim et al., 2004; Di Martino et al., 2001; 
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DiMartino et al., 2007).  These works mostly looked at when the transitions occur from 
the anhydrous form to the other forms through changes in relative humidity, or slow 
cooling crystallization in water or a 64 mole % methanol-in-water mixture.  They also 
examined how one could transition from a more hydrated to a less hydrated form either 









Figure 2.12. Schematic showing transitions of 4 known pseudopolymorphic forms of 
sodium naproxen. 
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 The structure for the monohydrated form of sodium naproxen has been 
solved, while those of the dihydrated and tetrahydrated form have not been determined.  
Table 2.5 shows the cell parameters for the monohydrated form compared to those of the 
anhydrous form shown in the previous section (Kim et al., 1990). 
 
 
Table 2.5. Comparison of anhydrated and monohydrated sodium naproxen unit cell 
parameters. 
 
Parameter Anhydrate Monohydrate 
Crystal Class Monoclinic Monoclinic 
Space Group P21 P21 
Crystal Habit Prism, colorless Prism, colorless 
Unit Cell Lengths a = 9.969 Å a = 21.177 Å 
 b = 5.9346 Å b = 5.785 Å 
 c = 20.823 Å c = 5.443 Å 
Unit Cell Angles α = 90° α = 90° 
 β = 102.025° β = 91.41° 
 γ = 90° γ = 90° 
Cell Volume 1204.9 Å3 666.61 Å3 
 
 
The dihydrated form of sodium naproxen has been characterized as a channel 
hydrate (Kim and Rousseau, 2004).  Upon dehydration, small crack can been seen in the 
crystal, using scanning electron microscopy (SEM), where the water being removed has 
created small channels to escape from the center of the crystal.  Highly hydrated forms of 
sodium naproxen have shown to have multiple steps for dehydration, passing through 
other known pseudopolymorphic forms before arriving at the anhydrous form (Kim and 
Rousseau, 2005; DiMartino et al., 2006).  In addition, each of the hydrated forms has 
exhibited dehydration at low temperatures, which is another indication that they are 
indeed channel hydrates. 
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CHAPTER 3  
SOLUBILITY OF SODIUM NAPROXEN IN ALCOHOL-WATER 
SOLVENT SYSTEMS 
 
One way to increase the yield of a solid product or to alter the solid state is to add 
organic alcohols to aqueous solutions during the crystal process, creating a salting-out 
effect, and/or forming a different polymorph or pseudopolymorph.  Some work has been 
done on the solubility of sodium naproxen in 64 mole % methanol-in-water solution 
(Kim, 2005), but little has been done beyond that work.  In this chapter, solubilities of 
sodium naproxen in 10 mole % methanol-in-water, 25 mole % methanol-in-water, 47 
mole % methanol-in-water, pure methanol, 14.5 mole % ethanol-in-water, 44 mole % 
ethanol-in-water, 67 mole % ethanol-in-water, 79 mole % ethanol-in-water, and pure 
ethanol were obtained by measuring equilibrium concentrations over a temperature range 
of approximately 10°C to 40°C. 
3.1 Experimental Section 
3.1.1 Apparatus 
The apparatus to determine the solubility of sodium naproxen in mixed solvent 
systems included two equilibrium cells in series along with a circulating cooling/heating 
bath to control temperature.  The equilibrium cells were merely capped 100-mL, UV-
coated Pyrex bottles.  UV-coated bottles were used because degradation of sodium 
naproxen in aqueous solutions has been reported; the degradation is fostered by light, 
especially UV (Moore and Chappuis, 1988).  The bottles were submerged in water at a 
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desired temperature that was controlled by a jacketed vessel.  A magnetic stirring bar was 
inserted into each equilibrium cell to create mixing by placing the cells on a stirring plate.  
The jacketed vessels containing the immersed equilibrium cells were connected to a 
circulating bath with temperature control.  A diagram of the apparatus is given in Figure 
3.1.  The equilibrium cells were placed under a prepared UV-protecting set-up or 





Figure 3.1. Schematic of equilibrium apparatus including equilibrium cells and 




Liquid samples from the equilibrium cells were withdrawn using a syringe, filter, 
and needle set-up.  A 15 gauge, stainless-steel needle (inside diameter ~ 1.7 mm) was 
used to exclude any large crystal from entering the liquid sample.  The needle was 
attached to a 0.2 µm syringe filter to remove any smaller crystals from the liquid sample 
collected in an attached 5 mL plastic syringe.  A diagram of the sampling apparatus is 











The anhydrous sodium naproxen (ASN) used in the experiments was provided by 
Albemarle Corp., and was used without further processing or purification.  Mixed 
solvents were prepared using HPLC-grade methanol (purchased from Fisher Scientific), 
water, and ethanol (purchased from VWR).  The alcohols were dried overnight using 
class 3A molecular sieves.  Solutions were prepared with the following molar methanol 
concentrations in water: 0, 0.10, 0.25, 0.44, and 1.00 mole/L.  The following molar 
concentrations of ethanol-in-water were also prepared: 0.145, 0.44, 0.67, 0.79 and 1.00 
mol/L.  Preparation of the solvents for specific molar concentration was determined by 
weight and then converted to the corresponding molar concentration.  Large batches of 
the solutions were prepared so as not to have varying concentrations across experiments.  
When not in use the lids of the solvents containers were paraffin wrapped and the solvent 
stored in a refrigerator to prevent evaporation of the solvent. 
3.1.3 Experimental Procedure 
The slurry solutions for equilibrium solubility studies were prepared by batch 
cooling crystallization.  Approximately 50 ml of solvent was added to the equilibrium 
cell, which was heated or cooled to the appropriate temperature.  The solvent was 
allowed to reach the desired equilibrium temperature, and then sodium naproxen was 
 38
slowly added until it no longer dissolved.  The solution was stirred for at least twenty 
minutes; if all the sodium naproxen dissolved, more was added.  Once the solution was 
considered saturated, the temperature was raised to about 10°C above the equilibrium 
temperature being measured,  so that all the existing crystals were dissolved. The solution 
then was cooled, at an approximate cooling rate of 0.6° per minute, to the original 
temperature.  The system conditions were then held constant for at least 15 hours to allow 
the system to reach equilibrium. 
This procedure was carried out for each of the solvent concentrations across an 
approximate temperature range of 10°C to 40°C in 5° increment.  Experiments were 
generally run in triplicate. 
3.1.4 Sampling Protocol 
Liquid sampling at temperatures greatly above or below room temperature, 
required heating or cooling of the needle prior to sampling so as not disturb the 
equilibrium concentration.  To do this, the needle was place in a refrigerator or an oven 
prior to sampling.  The sample was then withdrawn using the needle, filter, and syringe 
set-up and 2-3 drops of the sample were immediately placed in four individual pre-
weighed HPLC vials with a known mass of HPLC water.  Immediately after sampling, 
the temperature of the solution was measured and recorded using a K-type thermocouple 
attached to a thermometer. 
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3.2 High Performance Liquid Chromatography (HPLC) 
3.2.1 Equipment 
Solute concentration was measured using a Shimadzu® HPLC system that 
consisted of a SCL-10Avp system controller, a LC-10ATvp solvent-delivery system,  
FCV-10ALvp gradient flow control value , a DGU-14A on-line degasser, a SIL-10Avp 
auto injector, and a SPD-10Avp UV-VIS spectrophotometric detector.  The system used a 
reverse-phase packed column (Microsorb-MV, 100-3 C18 100 x 4.6mm from Varian) for 
separation.  Two mobile phases were utilized; Solvent A was HPLC grade acetonitrile 




Table 3.6. Acquisition parameters for HPLC. 
 
Items Parameters 
Pumps Mode Low Pressure Gradient Parameters
Total Flow Rate 1 mL/min 
Pressure Limits 0.0 – 20.0 MPa 
Lamp for Detector Deuterium (D2) 
Wavelength for Acquisition Channel 254 nm 
Sampling Frequency 5 Hz 
Acquisition Time 8 min 
Injection Volume 10 µL 
Sampling Speed 10 µL/sec 




The internal standard method for determining concentration using HPLC was 
used, with butyrophenone as the internal standard.  A typical separation by HPLC is 
illustrated in Figure 3.3.  The Y-axis is in minutes and the X-axis is in mVolts.  The peak 
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for sodium naproxen was seen slightly before 3 minutes and the internal standard eluted 









 Although there were slight tails on the measurements, the separation was still 
complete since the peaks do not overlap. 
3.2.2 Calibrations 
The internal standard method was used to determine the concentration of sodium 
naproxen in the samples.  This was necessary since the efficiency of the column, 
sensitivity of the detector, and injection amount do not stay the same for every run.  
Butyrophenone purchased from Sigma Aldrich was used as the internal standard.  The 
internal standard method assumes that the ratio of the peak areas for the sample to the 
internal standard is proportional to the ratio of the sample concentration to the internal 






= +                                                                  (3-12) 
Where Ai is the peak area, Ci is the concentration in g/kg of solution, and k and b  are 
constants.  Subscripts S and I refer to the sample and internal standard, respectively.  By 
preparing solutions of known concentrations of sodium naproxen and butyrophenone and 
determining their peak areas using the HPLC, k and b can be determined.  Stock solution 
of sodium naproxen with the proper solvent (
0S
C ~10 g/kg) and butyrophenone with 
acetonitrile (
0I
C ~8 g/kg) were prepared.  Nine calibration samples were then prepared 
according to Figure 3.4 with concentration range of about 0.5 to 4 g ASN/kg (
1S
C ) and 
about 0.8 to 2.6 g butyrophenone/kg (
1I
C ).  These ranges were determined based on the 
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= +                                                                                       (3-13). 
SA  and IA can be obtained from the chromatogram and the concentrations can be 



































and fitting a least squares linear regression, k and 
b were obtained.  Calibrations were performed routinely since the efficiency of the 
column degraded with time; they were also performed for each alcohol-water mixture.  
An example of a calibration plot is given in Figure 3.5: 
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Figure 3.5.  Example of calibration curve. 
 
 
3.2.3 Dilution of Samples 
 
Dilution of the samples was necessary to prevent crystallization and to increase 
the accuracy of the HPLC, since analysis was more reliable at lower concentrations.  
Approximately 0.1 g of the sample (
0S
M ) was immediately diluted with approximately 1 
g of water ( WM ) as described in the sampling protocol.  This solution was then vortexed 
for at least 7 minutes to ensure the solution was well mixed.  Approximately 0.2 g of the 
diluted sample (
1S
M ) was then added to an HPLC vial containing approximately 1 g of 
acetonitrile ( AM ) and 0.1 g of the stock internal standard ( IM ).  The dilution scheme is 
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=                                                                            (3-3) 
Where SiC refers to the concentration of the solute at diluting step i, 2SA is the area as 
reported by the HPLC of sodium naproxen in the solution, and 
1I
A is the area as reported 
by the HPLC of the internal standard in the solution. 
 
3.3 Results and Discussion 
3.3.1 Solubility Analysis 
 
The solubility of sodium naproxen in aqueous systems has been reported by Kim 
et al. (2005).  In the present study, the solubility of sodium naproxen in both methanol-
water and ethanol-water systems was obtained by the methods outlined above.  The 
average solubilities of sodium naproxen (g anhydrous sodium naproxen/kg solution) at 
various temperatures and methanol-water solutions are given in 
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Table 3.7, Table 3.8, Table 3.9, and Table 3.10, along with the sample standard 
deviations.  Sample standard deviations were calculated from a total of eight to twelve 
samples that were taken from three to four experimental set-ups and were computed 











− ∑                                                                        (3-4), 
where S is the sample standard deviation, n is the number of samples, Xi is the sample 
value of the i-th term, and X is the mean of the sample set.  Standard deviations stem 
from the saturation of the solution, sampling technique, sample preparation, and HPLC 
analysis. 
For comparison reasons, previous solubility data of anhydrous sodium naproxen 
in pure water solutions (Méndez del Rio, 2004) and aqueous solutions containing 64 mole 
% methanol-in-water (Kim, 2005) are shown in Table 3.11, and Table 3.12, respectively.  
The data are graphically presented in Figure 3.7 for water-methanol mixture and in 
Figure 3.8 for water-ethanol mixtures.  Generally, the solubility of sodium naproxen 
increased with increasing methanol concentration, except at higher temperatures.  For 
ethanol mixtures, solubility was greater in water except for water-ethanol mixtures at 
14.5 mol% and 44 mol%.  Ethanol solutions tended to show a traditional “salting-out” 




Table 3.7. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
11.4 73 ± 6 
15.6 108 ± 1 
20.0 178 ± 4 
24.8 263 ± 4 
29.4 318 ± 5 
33.0 386 ± 6 




Table 3.8. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
10.6 157 ± 10 
15.3 225 ± 4 
20.3 299 ± 10 
25.0 318 ± 4 




Table 3.9. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
11.2 228 ± 7 
15.6 259 ± 6 
20.2 293 ± 5 
25.0 325 ± 2 
29.6 345 ± 4 
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Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
10.4 214 ± 2 
15.3 216 ± 5 
20.4 224 ± 3 
25.3 244 ± 3 
29.9 242 ± 8 
34.4 243 ± 8 

























Table 3.12. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 














Table 3.13. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
10.5 118 ± 6 
13.5 129 ± 1 
16.6 167 ± 2 
20.6 250 ± 4 
23.5 276 ± 2 
25.5 295 ± 12 
29.6 337 ± 4 




Table 3.14. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
103 148 ± 2 
12.4 151 ± 3 
15.2 164 ± 3 
20.0 182 ± 2 
24.6 201 ± 5 




Table 3.15. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
10.8 71 ± 1 
15.7 81 ± 4 
18.1 87 ± 2 
20.6 91 ± 4 
22.6 97 ± 6 
25.8 112 ± 3 
29.8 125 ± 4 
34.2 147 ± 6 
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Table 3.16. Experimental solubility of anhydrous sodium naproxen in aqueous solutions 




Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
10.8 47 ± 2 
15.8 54 ± 3 
20.3 62 ± 1 
25.1 73 ± 4 
29.8 78 ± 1 
34.5 86 ± 2 








Solubility ± Standard Deviation 
(g Anhydrous Sodium Naproxen/kg Solution) 
11.0 14 ± 1 
15.6 16 ± 1 
20.5 19 ± 1 
25.1 23 ± 1 
29.7 26 ± 1  
34.5 28 ± 1 

























































Figure 3.8.  Anhydrous sodium naproxen solubility in water-ethanol systems. 
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3.3.2 Transitions between Pseudopolymorphs 
Careful inspection of the plots of data in Figure 3.7 and Figure 3.8, revealed 
discontinuities in the data for each of the solvent concentrations.  These discontinuities 
were be attributed to changes in the solid state of sodium naproxen in equilibrium with 
the solutions and are better observed in Figure 3.9, Figure 3.10, Figure 3.11, and Figure 
3.12, which separates the data based on the solid state in equilibrium with the solution.  
Generally, at lower temperatures one pseudopolymorph was in equilibrium with a 
particular solution, but at higher temperatures the pseudopolymorphic phase changed.  
This was true in all of the solutions examined except for those containing 47 mole % 
methanol and 67 mole % ethanol-in-water.  Changes in solid state were verified by 
thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and powder 



















































































































































Figure 3.12. Empirical fits to the solubility data of pure methanol and pure ethanol. 
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Table 3.18 shows the pseudopolymorphic transitions of sodium naproxen in the 
solvent systems studied.  As previously reported, a dihydrate to anhydrate solid-state 
transition was observed when the solvent was pure water (Mendez del Rio, 2004).  In 10 
mole % methanol-in-water and 14.5 % ethanol-in-water solutions, a solvate to dihydrate 
transition occurred.  A dihydrate to monohydrate transition was apparent with 25 mole % 
methanol, 64 mole % methanol, 44 mole % ethanol, and 79 mole % ethanol-in-water.  
When the pure alcohols were used a solvate-to-anhydrate transition was observed.  There 
appeared to be no transition in both the 47 mole % methanol and 67 mole % ethanol-in-












Low T → High T 
0% 0% Dihydrate → Anhydrate 
10% 14.5% Solvate → Dihydrate 
25% 44% Dihydrate → Monohydrate 
47% 67% Dihydrate 
64% 79% Dihydrate → Monohydrate 






The solubility of sodium naproxen in mixed alcohol-water solvents and pure 
alcohols was measured using cooling crystallization to generate the equilibrated solid in 
an equilibrium cell.  Solution compositions were determined by reverse-phase HPLC.  
Addition of methanol to aqueous solutions generally caused a salting in effect, while 
addition of ethanol to aqueous solutions caused a salting out effect.  Additionally, 
pseudopolymorphic transformations were seen in some of the solutions across the 
temperatures ranges measured.  This shows that pseudopolymorphic forms can be 
controlled by varying the amount of organic alcohol present in the aqueous solutions. 
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CHAPTER 4  
TRANSITIONS OF PSEUDOPOLYMORPHIC FORMS IN 
ALCOHOL WATER SOLVENT SYSTEMS 
 
As discussed in the previous chapter, solid-state transitions have been found in 
some of the sodium naproxen-alcohol-water systems due to temperature changes. This 
can be observed by examining the discontinuities in solubility data and then proven 
through analysis of crystal samples. The identity of each of the solid states is confirmed 
by polarized light microscopy (PLM), thermogravimetric analysis (TGA), differential 
scanning calorimetry (DSC) and powder x-ray diffraction (PXRD).  The solubility data 
measured previously can be correlated using the van’t Hoff equation, as discussed in 
Chapter 2, based on the solid state present in solution to determine the actual transition 
temperature for each of the solvent mixtures.  Finally, the transitions can then be related 
to water activity in the solutions at the transition point to determine what role the activity 
of water plays in the transitions. 
4.1 Solid-State Analysis 
The apparatus, materials, and experimental procedure were described in the 
previous chapter.  This chapter deals with the solid-state identification of the crystals in 
the slurry mixture. 
4.1.1 Sampling Protocol 
After equilibration, the slurry solution was vacuum filtered until there was no 
visible liquid being removed.  The crystals were then allowed to dry overnight in a dark 
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place at ambient conditions to remove any excess solvent on the surface of the crystals.  
They were then gently ground to a fine powder using a mortar and pestle so that they 
could be further analyzed for solid-state identification. 
4.1.2 Polarized Light Microscopy 
During recrystallization, crystals can change in size and shape.   This can be 
caused by kinetic factors, such as mixing intensity and temperature ramping rates, and by 
thermodynamic factors, such as polymorphism and solvent composition.  In this study, 
optical microscopy was used to observe changes in crystal size and shape based on 
pseudopolymorphism affected by temperature and solvent composition. 
Analysis of crystal samples from the slurry solution was performed under a Leica 
DM LM microscope equipped with a Sony DKS-5000 digital camera and an objective 
lens of 20X.  The microscope was equipped with a Sony DKC-5000 digital camera that 
converted the focused light into a digital signal, which was then visualized by Image-Pro 
Plus version 4.5. 
A small amount of slurry was placed on a glass slide, which was cooled or heated 
according to the temperature of the slurry solution, and covered with a cover glass.  The 
glassware was cooled or heated due to the instability of the crystals in solutions.  For 
example, with crystal samples taken at low temperatures, the solid would quickly 
dissolve once placed under the microscope. 
4.1.3 Thermogravimetric analysis 
The TGA is used to determine how much solvent is bound in the crystals and 
gives information on the molecular ratio of solvent to solute in the pseudopolymorphic 
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forms.  Mass loss of the sodium naproxen samples was measured using a TG/DTA 320 
instrument manufactured by Seiko Instrument Inc.  Crystal samples of 10 to 15 mg were 
heated from 22°C to 130°C in aluminum pans that were 5 mm in diameter.  A ramping 
rate of 10°C/min was used with a nitrogen purge rate of 90 mL/min.  As recommended 
by Di Martino et al (2001), all TGA runs were carried out with open pans. 
4.1.4 Differential Scanning Calorimetry 
Desolvation and melting endotherms were measured using a DSC 220C 
instrument (Seiko Instrument Inc.) The temperature range of the experiments was 22 to 
290°C with a heating rate of 10°C/min and a nitrogen purge rate of 90 mL/min.  Crystal 
samples of 10 to 15 mg were placed in open aluminum pans with a diameter of 7 mm.  
The use of open aluminum pans was necessary to obtain quantitative evaluations of the 
desolvation energy (Di Martino, 2001).  The quantitative evaluation of energies 
associated with desolvation aided in the determination of the amount and type of solvent 
in the pseudopolymorphic forms. 
4.1.5 Powder X-Ray Diffraction 
Crystals were analyzed using PXRD analysis for final determination of solid-
state.  Each pseudopolymorph had a distinct diffraction pattern which can be used for 
quick and reliable identification.  A PANanlytical X-Pert Pro Alpha-1 diffractometer with 
copper Kα1 radiation was used in conjunction with the X’Celerator detector.  The PXRD 
pattern was made over a diffraction-angle (2θ) range of 10° to 80°, with a step size of 
0.02° and a counting time of 1 second per step. 
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4.2 Results and discussion 
4.2.1 Crystal Habit 
Initial identification of pseudopolymorphs was based on crystal habit as 
determined by PLM images.  Figure 4.1 shows PLM images of the anhydrate, 
monohydrate, and dihydrate forms of sodium naproxen.  
 The anhydrous form was thin and plate-like (Figure 4.1 (a)), which was in 
contrast to the monohydrate form (Figure 4.1 (b)) which was plate-like but larger and not 
as thin.  The dihydrated form (Figure 4.1 (c)) was the easiest form to distinguish due to 
its slender, needle-like characteristics.  Because of the instability of the solvated forms, 
sharp PLM images were not possible with these species. The methanol solvate form 
(Figure 4.1 (d)) of sodium naproxen was small in size and possibly prism-like in habit.  
The ethanol solvate form (Figure 4.1 (e)) could also have had a prism-like habit similar to 









Figure 4.1. Photomicrographs of pseudopolymorphic forms of sodium naproxen (a) 






4.2.2 Thermal Analysis 
Theoretical water contents for the monohydrate and dihydrate forms (the 
previously know pseudopolymorphic forms) of sodium naproxen was 6.67 wt% and 12.5 
wt%, respectively.  Additionally the dihydrated form was known to have two separate 
dehydration steps relating to the release of two structurally different water molecules 
(Kim and Rousseau, 2004).  Of course the anhydrate form contained no water and no 
weight loss was to be expected.  The heats of dehydration for the monohydrate and 
dihydrate have also been shown to be 207.3 J/g of the monohydrate and 376.8 J/g of the 
dihydrate (Kim and Rousseau, 2004).  If the anhydrous species was used as the basis, the 
heats of dehydration become 220.5 and 427.6 J/g of the anhydrate, respectively.  Based 
on this information the TGA and DSC data of each solid crystal form was analyzed and 





























Figure 4.2. TGA curves of (a) anhydrous, (b) monohydrated, (c) methanol solvated, (d) 
dihydrated, and (e) ethanol solvated forms of sodium naproxen. 
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 Figure 4.2 shows typical TGA curves for the pseudopolymorphic forms of sodium 
naproxen evaluated as part of the present work.  A mass loss of 0.490 wt% was typical 
for the anhydrate, while the monohydrate and dihydrate saw typical mass losses of 6.70 
wt% and 12.3 wt%, respectively.  For the solvated species, mass losses were 11.8 wt% 
and 13.2 wt% for the methanol and ethanol solvated forms of sodium naproxen, 
respectively.  The mass losses reported for the hydrated forms of sodium naproxen were 
in agreement with theoretical values.  The mass losses reported for the solvated forms 
corresponded to a 1:1 ratio of methanol to sodium naproxen and a 0.86:1 ratio of ethanol 
to sodium naproxen.  No alcohol solvated forms of sodium naproxen had previously been 
reported. 
 The monohydrated and methanol solvated forms showed a steady desolvation to 
the final anhydrous form, while the dihydrated and ethanol solvated forms seemed to 
have multiple steps for removal of solvent, as shown by the derivates of the TGA mass 
loss shown in Figure 4.3.  There were two peaks evident for the dihydrate and ethanol 
solvate, but only one peak was seen during mass loss of the monohydrate and methanol 
solvate.  Additionally, initial removal of solvent from the ethanol solvate forms took 
place immediately upon measurement, as opposed to the other desolvations which 
seemed to begin shortly after measurement initiates.  This may have suggested instability 
of the ethanol solvate since desolvation began with a small elevation in temperature.  The 
task here was merely to identify which pseudopolymorphic form was seen in equilibrium 




































Figure 4.3.  Derivative of TGA curves of the monohydrate, methanol solvate, dihydrate, 
and ethanol solvate of sodium naproxen. 
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Similar to the TGA curves presented in Figure 4.2, Figure 4.4 represents DSC 
endotherms of the pseudopolymorphic forms to aid in further identification. As can be 
seen, the endotherms for solvent removal took place between 25°C and 115°C.   The 
endotherm above 250°C corresponded to the melting of sodium naproxen.  Each 
pseudopolymorphic form had a distinct endotherm shape and energy associated with 
removal of the solvent.  Since the endotherms of the monohydrated and dihydrated 
species had been reported previously and were 207.3 J/g monohydrate and 376.8 J/g 
dihydrate (Kim, 2004), comparison to experimental endotherms, in these studies, aided in 
distinguishing pseudopolymorphic forms.  In the present study, additional endotherms 
were found for the methanol and ethanol solvated forms of sodium naproxen, they were 
found to be 204 ± 2 and 217 ± 17 J/g solvate, respectively.  These values were converted 
to J/g anhydrate to make comparisons to other pseudopolymorphic forms easier and were 
230 and 251 J/g anhydrate for the methanol and ethanol solvate, respectively.  For the 
previously mentioned monohydrate and dihydrate species the energy of desolvation based 


















Figure 4.4. DSC endotherms for (a) Anhydrous, (b) monohydrated, (c) dihydrated, (d) 







4.2.3 Powder X-ray Diffraction Patterns 
PXRD was the final step for solid-state identification.  Each pseudopolymorphic 
form had a distinct PXRD pattern that was independent of the crystal habit.  The PXRD 
diffraction patterns for the anhydrate, monohydrate, and dihydrate of sodium naproxen 
were known prior to the present research (Kim, 2004).  The PXRD patterns determined 
here for the methanol and ethanol solvated forms of sodium naproxen were compared to 

























Figure 4.5. PXRD patterns for (a) anhydrous, (b) methanol solvated, (c) ethanol solvated, 
(d) monohydrated, and (e) dihydrated forms of sodium naproxen. 
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4.2.4 Pseudopolymorphic Forms From Crystal Analysis 
Using the above mentioned solid-state identification techniques (PLM imaging, 
TGA, DSC, and PXRD), the solid states in equilibrium with the solvent systems studied 
here were determined and are listed in Table 4.1 and Table 4.2 for the methanol and 
ethanol systems, respectively.  For example, for a methanol-water system with a 
methanol concentration of 10 mole %, a transition from the solvate to the dihydrate was 
seen when going from lower to higher equilibrium temperatures. 
 
 





(Lower T → Higher T) 
0 Dihydrate → Anhydrate 
10 Solvate → Dihydrate 
25 Solvate → Dihydrate 
47 Dihydrate 
64 Dihydrate → Monohydrate 









(Lower T → Higher T) 
0 Dihydrate → Anhydrate 
14.5 Solvate → Dihydrate 
44 Solvate → Dihydrate 
67 Dihydrate 
79 Dihydrate → Monohydrate 





It is interesting to note that the same solid states were identified for 10 mol% 
methanol/14.5 mol% ethanol-in-water, 25 mol% methanol/44 mol% ethanol-in-water, 47 
mol% methanol/67 mol% ethanol-in-water, 64 mol% methanol/79 mol% ethanol-in-
water and pure methanol/pure ethanol solutions.  Also the discovery of organic alcohol 
solvates of sodium naproxen should be mentioned since previous alcohol solvates were 
not known. 
4.2.5 Determining Solid-State Transitions with the Van’t Hoff Correlation 






= − +                                                                               (2-10) 
For systems that fit the assumptions leading to this equation, a plot of the natural 
logarithm of solubility (in mole fraction) versus the inverse of temperature should be 
linear with the slope and the intercept related to the enthalpy and entropy of dissolution, 
respectively.  The enthalpy and entropy of dissolution are specific to the particular solid 
that is in equilibrium with the solution.  So if different solids are present in the same 
solutions there will be distinct relationships for each solid.  Figure 4.6 through Figure 







































T = 297.3 K
 



































T = 291.6 K
y = 5.7524 - 2.674x
R2=0.94
y = 22.643 - 7.6001x
R2=1.00
 

































y = 5.7331 - 2.6392x
R2 = 0.99
 




































y = 8.2114- 3.3572x
R2 = 1.00
y = 2.4840 - 1.6812x
R2 = 0.99
T = 292.6 K
 


































y = -0.18352 - 0.91776x
R2 = 0.86
y = -3.1342 - 0.032922x
R2 = 0.99
T = 299.9 K
 

































y = 21.92 -7.4967x
R2 = 0.93
y = 11.028 - 4.2847
R2 = 1.00
T = 294.9 K
 


































y = 3.6065 - 2.1276x
R2 = 0.93
y = 4.0049 - 2.2428x
R2 = 1.00
T = 289.0 K
 


































y = 5.9337 - 3.0222x
R2 = 0.99
 


































y = 2.1427 - 1.9506x
R2 = 0.97
y = 4.8247 - 2.749x
R2 = 0.99
T = 297.7 K
 


































y = -1.125 - 1.2699x
R2 = 0.97
y = 5.1941 - 3.1811x
R2 = 1.00
T = 302.5 K
 
Figure 4.15. Van't Hoff plot of pure ethanol solvent. 
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The enthalpies and entropies of dissolution extracted from the slopes and 
intercepts of the best-fit linear regressions are listed in Table 4.3 and Table 4.4 for 
methanol-water and ethanol-water solvent mixtures. 
 
 
Table 4.3. Enthalpy and entropy of dissolution of methanol-water mixed solvents from 












Solvate 81.3 242.6 10 Dihydrate 46.0 123.9 
Solvate 63.2 452.9 25 Dihydrate 22.4 188.3 
47 Dihydrate 22.2 45.9 
Dihydrate 27.9 68.3 64 Monohydrate 13.4 20.7 




Table 4.4. Enthalpy and entropy of dissolution of ethanol-water mixed solvents from 
van't Hoff plots. 
 
Ethanol Concentration 





Solvate 62.3 182 14.5 Dihydrate 35.6 91.7 
Solvate 17.7 30.0 44 Dihydrate 18.6 33.3 
67 Dihydrate 25.1 49.3 
Dihydrate 22.9 40.1 79 Monohydrate 16.2 17.8 




For the dihydrate and anhydrate in pure water the enthalpy of dissolution was 56.2 
and 33.8 kJ/mol ASN, respectively (Kim, 2005). The enthalpy of dissolution decreased 
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for each pseudopolymorph as the concentration of the alcohol increased in the solvent.  
Dissolution can be viewed as occurring in three steps: 
(1) breaking solute-solute attractions (endothermic) 
(2) breaking solvent-solvent attractions (endothermic) 
(3) Forming solvent-solute attractions (exothermic). 
Since the enthalpy of dissolution seemed to decrease as the concentration of alcohol in 
the solvent increased, this would mean the breaking of solvent-solvent bonds was less 
endothermic and/or the forming of solvent-solute bonds was more exothermic.  The heat 
of vaporization of water is high, signaling strong solvent-solvent interactions, as the 
amount of alcohol present in the solvent increased; these solvent-solvent interactions 
between water molecules would decrease.  This meant a decrease in the endothermic 
nature of the solvent-solvent interactions pertaining to dissolution.  Clearly, the decrease 
in enthalpies of dissolution was expected as the amount of alcohol increased in the 
solvent. 
Pertaining to the differences in dissolution enthalpies for different 
pseudopolymorphs, Kim et al. (2005) were able to explain that in an enantiotropic 
system, a pseudopolymorph with a lower degree of hydration was more stable over a 




H O H O2 (v) 2 (l)
d
sol, sol, d, vap,H O
100
T
ˆ ˆ ˆ ˆ( )
( ) ( ) .
n m n m
p p
H H H n m H
n m C C dT
→∆ −∆ = ∆ − − ∆
+ − −∫
                                     (4-1). 
Where solĤ∆ is the heat of dissolution, dĤ∆  is the heat of dehydration, vapĤ∆  is the heat 
of vaporization, Td is the dehydration temperature, Cp is the heat capacity, and m and n 
are degrees of hydration where m<n.  The first term of the equation on the right hand side 
is always greater than the second, and the integral term is small; therefore, the right-hand 
side is always positive.    Consequently, the heat of dissolution of hydration state m is 
always smaller than the heat of dissolution of hydration state n.   
This can also be related back to the van’t Hoff plots.  If a system exhibits 
transitions according to the van’t Hoff plot, the slope of the line must be smaller for the 
pseudopolymorph at the higher temperatures than that of the pseudopolymorphs at the 
lower temperatures, in order for the lines to cross. Since a smaller slope for the van’t Hoff 
plot corresponds to less hydrated pseudopolymorph, this means that the less hydrated 
pseudopolymorph must be in equilibrium at the higher temperatures.  Therefore, the 
dihydrate will exist at lower temperatures and the anhydrate at higher temperatures in 
pure water solvent systems.  When considering a dihydrate to monohydrate transition, as 
in solutions of 64 mol% methanol and 79 mol% ethanol-in-water.  The dihydrate will 
again be present at equilibrium at lower temperatures and have a larger enthalpy of 
dissolution than the monohydrate, which was present at higher temperatures.  A similar 
analysis for solvate to dihydrate transitions is shown in chapter 5. 
Table 4.5 and Table 4.6 are a summary of the figures presented above.
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Solid State Transition 
(Lower T → Higher T) 
Transition Temperature
(K) 
0 Dihydrate → Anhydrate 302 
10 Solvate → Dihydrate 297 
25 Solvate → Dihydrate 292 
47 Dihydrate --- 
64 Dihydrate → Monohydrate 293 









Solid State Transition 
(Lower T → Higher T) 
Transition Temperature
(K) 
0 Dihydrate → Anhydrate 302 
14.5 Solvate → Dihydrate 295 
44 Solvate → Dihydrate 289 
67 Dihydrate --- 
79 Dihydrate → Monohydrate 298 




They list the solid state transitions that were observed and the temperatures at which 
theses transitions occurred according to the alcohol content of the mixed solvent.  The 
transition in pure water is also listed (Kim, 2005). 
  As the fraction of alcohol in the solvent increased the transition temperature 
decreased, up to the point where no transition was observed.  Then, as the fraction of 
alcohol in the solvent continued to increase, the transition temperature began to increase 
as well.  These changes in transitions temperature can be better explained by looking at 
changes in water activity. 
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4.3 Role of Water Activity in Pseudopolymorphic Transitions 
Khanhari and Grant (1995) postulated that the activity of water in a mixture plays 
an important role in determining the solubility and hydration state of a hydrate.  In their 
analysis, formation of a hydrated crystal was represented by the following chemical 
equation: 
(solid) 2 2 (solid)A H O A H Om m+ ←⎯→ ⋅ .      
The equilibrium constant, hK , for the above process can be represented by 
2 (solid)
(solid) 2
[ H O ]





=                                                                       (4-2) 
       
 
Where 2 (solid)[ H O ]a A m⋅ , (solid)[ ]a A , and 2[H O]a are the activities of the hydrate crystal, 
anhydrate crystal, and water, respectively.  If the standard states of the solids are assumed 





−=                                                                                        (4-3) 
where m is the number of moles in the stoichiometric equation that are taken up by one 
mole of the less hydrated species.   
The same results can be obtained in a solvent-mediated transformation with the 
following chemical equation: 
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1 2
(s) 2 (l) (aq) 2 (l) 2 (s)H O H O H O
K KA m A m A m⎯⎯→ ⎯⎯→+ + ⋅←⎯⎯ ←⎯⎯                         (4-4) 













[ H O ]





=                                                                          (4-6) 
Where (s)[ ]a A  is the activity of the solid in solution.  The overall equilibrium constant 
was evaluated by multiplying Equation (4-4) with Equation (4-5) to arrive at the 
following equation  
1 2 2* [H O]
mK K a −=                                                                                (4-7), 
which has the same implications as Equation (4-3). 
The activity of water in the crystallization medium depends on the composition of 
the water / solvent mixture.  Values of the water activity, wa , can be calculated in such 
mixtures from literature values or thermodynamic approximations of the activity 
coefficient of water, wγ , and the mole fraction of water, wx , by  
www xa γ=                                                                                              (4- 8) 
 
There then exists an equilibrium water activity where at higher levels one form of the 
hydrate crystal is stable and at water activities lower than the equilibrium water activity 
another form is more stable.  Studies have shown that the hydration state of a stable 
crystal species depends on the water activity in the crystallization medium (Zhu et al., 
1996; Zhu and Grant 1996; Qu et al., 2006).  This method asserts that wa  in the mixture 
is the major variable determining the phase of the pseudopolymorph and that the 
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dissolved drug in the solvent mixture influences wa  to a smaller extent than the organic 
solvent. 
In addition, Qu et al. (2006) have shown that the hydration state of a mixed hydrate 
formed from a water-ethanol solution is dependent on both the water activity and the 
temperature of the solution for carbamazepine.  As the transition temperature increased, 
so did the equilibrium water activity where the transition from one hydrate species to the 
other was observed (see Figure 4.16).  For the carbamazepine anhydrous(CBZA) / 
hydrate (CBZH) system in water-ethanol mixtures, the equilibrium water activity 








The activity of water was calculated at the transition point using the concentration 
of alcohol in the solvent and the transition temperature extracted from the van’t Hoff 
plots.  Assuming the solute did not affect the activity of water, a two-component Wilson 
equation was used to establish an activity coefficient, which was then substituted into 










































xxxγ      (4- 10) 
where water = 1 and methanol or ethanol = 2 and ix  is the mole fraction of species i , 11Λ  




























υ                                                                   (4-12) 
where iυ  the molar liquid volume of component i and the ijλ  are energies of interaction 
between the molecules designated in the subscripts. All values are known for methanol-
water and ethanol-water systems (Smith and Van Ness, 1996). With wγ  and the 
concentration of alcohol in solution, wa  was calculated based on Equation (4-8).  Figure 
4.17 shows the activity of water at the transition points versus the mole percent of alcohol 





















Alcohol Content (Mole %)  
Figure 4.17. Water activity versus alcohol content for methanol-water and ethanol-water 
mixed solvent systems. 
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Note that the activities of water at which transitions occurred were the same irrespective 
of the alcohol in the solvent; i.e. transitions took place at water activities of 0.9, 0.8, and 
0.5.  Clearly, then, water activity is a controlling thermodynamic factor for 
pseudopolymorphic transitions.   
It was interesting to note that the transitions with 10 mol% methanol and 14.5 
mol% ethanol and with 25 mol% methanol and 44 mol% ethanol represented  transitions 
from solvate to dihydrate but occurred at different water activities.  Although the change 
in pseudopolymorphic form was the same at these points the water activity was actually 
different.  This would suggest that there are preferential ranges of water activity for a 
certain transition, and within that range transitions will actually occur at specific points.  
For these transitions the equilibrium constant would depend both on the water activity 
and the alcohol activity of the solvent.  
4.4 Role of Alcohol Activity in Pseudopolymorphic Transitions 
On a similar note, the activities of alcohol in the solutions were also compared to 
see if alcohol activity had significance in terms of the transitions of pseudopolymorphic 
forms. As seen in Figure 4.18, there was no correspondence among alcohol activity and 
transitions of the pseudopolymorphs (transition pairs are circled).  Water activity plays 
the dominant role in pseudopolymorphic transitions.  This was most likely due to the fact 
that when a solvated form is present for a transition, the dihydrated form is also present 
so the chemical equation for transition is 
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2 2A ROH 2H O A 2H O ROHm m⋅ + ↔ ⋅ + , 





−=                                                                       (4-13) 
Since m is always less than 2 in the studies presented here, water activity will 
dominates the equilibrium constant so the alcohol activity is not expected to play as great 
a role as the water activity, across alcohol solvents.   
Additionally, when comparing the methanol solvate-dihydrate transition with the 
ethanol solvate-dihydrate transition, the alcohol activities would not be expected to be the 
same since the transitions are actually different; an ethanol solvate would not form in 
methanol-water solutions.  This would mean different equilibrium constants and although 
the water activities coincide because they were the dominate player in the equilibrium 





















Alcohol Content (Mole %)  
Figure 4.18. Alcohol activity versus alcohol content of methanol-water and ethanol-water 
mixed solvent systems. 
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4.5 Conclusions 
The solubilities of sodium naproxen in methanol-water and ethanol-water 
mixtures, and in pure solvents of methanol and ethanol were measured.  In general, 
methanol solutions exhibited a salting-in effect compared to pure water.  For the ethanol 
solutions a salting-out effect was seen compared to the solubility of sodium naproxen in 
pure water.  The following pseudopolymorphs were identified:  anhydrate, monohydrate, 
dihydrate, methanol solvate, and ethanol solvate of sodium naproxen, existence of the 
alcohol solvates of sodium naproxen had not been previously reported.   
By changing the alcohol content in the solvent solution, varying 
pseudopolymorphic forms of sodium naproxen were produced in equilibrium with the 
solution.  This implies that solid-state formation of pseudopolymorphs and solubility can 
be controlled through solvent selection. 
The transition temperatures from one pseudopolymorphic form to another for 
each of the solvent concentrations were determined and were distinct from each other.  
The transition temperatures initially decreased as the concentration of alcohol in the 
solvent increased, until there was no transition with the 47 mol% methanol solvent and 
the 67 mol% ethanol-in-water solvent.  As the amount of alcohol increased past these 
points the transition temperatures began to increase. 
Additionally, using the extracted transition temperatures and Wilson’s equation to 
estimate the activity coefficient, the activities of water at the transition points was 
determined.  It was shown that independent of the alcohol content, transitions occurred at 
the same water activity for corresponding alcohol concentrations, while correlations with 
alcohol activity was not apparent.  This was explained by looking at the equation for the 
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equilibrium constant which was largely dependent on the water activity compared to the 
alcohol activity.  It was interesting to note that at the 10 mol% methanol/ 14.5 mol% 
ethanol-in-water and 25 mol% methanol/ 44 mol% ethanol-in-water pairs, the same 
pseudopolymorphic transition occurred even though the water activities at these points 
were different.  This would suggest that there was a range of water activities for 
pseudopolymorphic transition as opposed to one specific water activity when the 
transition would occur. 
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CHAPTER 5  
STABILITY OF SOLVATE-HYDRATE SYSTEMS 
In the previous chapter, a model by Kim et al. (2005) was used to explain 
pseudopolymorphic stability at high or lower temperatures based on the degree of 
solvation when the pseudopolymorphs only included anhydrate to hydrate transitions.  A 
modified approach was required to examine transitions between hydrates and solvates.  
The modification, as described below, allowed determination of heats of solution. 
5.1 Mixed-Solvent Thermodynamic Cycles 
The following two chemical equations describe dihydrate and methanol solvate 
formations: 
sol,A H O2∆H
2 (aq) 2 (l)MeOHA 2H O A + 2H O




(aq) (l)H OA MeOH A + MeOH
⋅⋅ ⎯⎯⎯⎯→                                                  (5-2) 
Using these equations, thermodynamic pathways shown in Figure 5.1 for Equation (5-1) 
and Figure 5.2 for Equation (5-2) were constructed, where Ts is the solution temperature 












C T C T
s s
A H O2 (l)p p
100 100


















C T C T
A H O2 (v)
d d
100 100









MeOH ˆ ˆsol,A mix∆H +∆H
ˆ





Figure 5.1. Thermodynamic cycle for dissolving dihydrate in methanol. 
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Based on this cycle the heat of solution was estimated by the following equation: 
2 2 2
H O H O A2 (v) 2 (l)
d d
d s s
A 2H O A H O2 2 (l)
s d






ˆ ˆ ˆ ˆ∆H [MeOH] = ∆H - 2∆H +∆H [MeOH]
ˆ+∆H (2H O,MeOH)
+ 2 [ - ]d d




C C T C T






             (5-3) 
where sol,ˆ∆H [ ]i j  is the molar heat of solution of component i in solvent j, d,ˆ∆H i is molar 
the heat of dehydration for component i, vap,ˆ∆H i is the molar heat of vaporization of 
component i, mixˆ∆H ( , )i j is the molar heat of mixing of components i and j, and pC i is the 
heat capacity of specie i.  Assuming the heat capacity of the dihydrate was approximately 
equal to the sum of the heat capacity of anhydrate and two moles of water, as justified by 
Khankari et al. (1992), the following was true: 
d d d
A 2H O A H O2 2 (l)
s s s
p p pd d + 2 d
T T T
T T T
C T C T C T
⋅
≈∫ ∫ ∫                                                       (5-4) 
Equation (5-3) then became 
2 2 2
H O H O2 (v) 2 (l)
d




ˆ ˆ ˆ ˆ∆H [MeOH] = ∆H - 2∆H +∆H [MeOH]
ˆ+∆H (2H O, MeOH)

























































Figure 5.2. Thermodynamic cycle for the dissolution of methanol solvate in water. 
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Using the same approach as presented above the equation for the dissolution of a 
methanol solvate in water was 
MeOH MeOH A(v) (l)
d d
d s s
A MeOH A MeOH(l)
s d d





ˆ ˆ ˆ ˆ∆H [H O] = ∆H -∆H +∆H [H O]
ˆ+∆H (H O, MeOH)
+ [ - ]d d




C C T C T





             (5-6) 
Again assuming that the methanol was present in liquid-like structure of the solvated 
species 
d d d
A MeOH A MeOH(l)
s s s
p p pd d + 2 d
T T T
T T T
C T C T C T
⋅
≈∫ ∫ ∫                                                     (5-7) 
equation (5-6) became 
MeOH MeOH(v) (l)
d




ˆ ˆ ˆ ˆ∆H [H O] = ∆H -∆H +∆H [H O]
ˆ+∆H (H O,MeOH)





                               (5-8)  
All of the values on the right hand sides of Equations (5-5) and (5-8) were known 
or could be estimated.  Using these equations, the heats of solution of the dihydrated 
species in methanol and of the methanol solvate in water could be estimated. But more 
importantly, the stability of one pseudopolymorph compared to the other can be 
determined.  
By subtracting Equation (5-2) from Equation (5-1), the following chemical 
equilibrium equation resulted: 
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sol,A H O sol,A MeOH2
2
∆H ∆H
2 (l) 2 (l)H O,MeOHA 2H O + MeOH A MeOH + 2H O
⋅ ⋅−⋅ ⎯⎯⎯⎯⎯⎯⎯→ ⋅               (5-9) 
This represents the transition from the dihydrated species to the methanol solvate and the 
following mathematical equations resulted from the thermodynamic cycles: 
2 2
2
H O H O2 (v) 2 (l)
d
MeOH MeOH(v) (l)








ˆ ˆ ˆ ˆ∆H [MeOH] ∆H [H O] = ∆H ∆H
ˆ ˆ- 2∆H +∆H
ˆ ˆ+∆H [MeOH]-∆H [H O]
ˆ∆H (2H O,MeOH)
ˆ-∆H (H O,MeOH)















              (5-10) 
From DSC data, the heat of dehydration of dihydrated sodium naproxen was 108.6 
kJ/mol and the heat of desolvation of the methanol solvated sodium naproxen was 57.9 
kJ/mol.  The heat of vaporization of water was 40.7 kJ/mol (Stark and Wallace, 1976) 
and the heat of vaporization of methanol was 34.5 kJ/mol (Yaws, 2003).  The heats of 
dissolution in pure solvents of the anhydrous form of sodium naproxen can be taken from 
previous van’t Hoff plots of solubility; sol,Aˆ kJ∆H [MeOH] = 0.274 mol  and 
sol,A 2
ˆ kJ∆H [H O] = 33.8 mol .  The heat capacity of water in the liquid state was 4.186 
J/g°C and in the vapor state was 2.009 J/g°C.  The heat capacities of methanol in its 
liquid and vapor states were 79.5 J·K-1·mol-1 and 52.3 J·K-1·mol-1, respectively (Yaws, 
2003).  The heat of mixing for methanol and water was small compared to the other 
values, but could be determined from literature values or from approximations.  
Additionally the heat of mixings needed here would be similar in value so both terms can 
 105
be neglected.  Substituting these values into Equation (5-10), 
2sol,A 2H O sol,A MeOH
ˆ ˆ kJ26.9 molH H⋅ ⋅∆ − ∆ = − . A negative value on the right-hand side of the 
equation meant the heat of dissolution of the dihydrated from of sodium naproxen was 
smaller than the heat of dissolution of the methanol solvated form of sodium naproxen.  
The smaller heat of solution meant a lower slope for the van’t Hoff plot which would 
correspond to the higher temperature range.  Therefore the dihydrated form was more 
stable at the higher equilibrium temperature than the alcohol solvated form.  The same 
analysis would apply to the ethanol solvated form of sodium naproxen and its 
transformation to the dihydrated sodium naproxen form, showing that the ethanol solvate 
form was more stable at lower temperatures than the dihydrate form. 
 Based on Equation (5-10), there was also a point when the heat of solution of the 
dihydrated species would be greater than that of the alcohol solvated form as the size of 
the alcohol solvent increases.  The terms relating to the dehydration of dihydrate, 
vaporization of water and the heat of dissolution of the anhydrous form in water remained 
the same.  The heat of solution of the anhydrate in the alcohol was small and had little 
effect on the overall sign of the equation.  The only two remaining terms of interest were 
the heat of desolvation of the alcohol and the heat of vaporization of the alcohol.  As will 
be seen in chapter 8, the heat of desolvation had small changes in terms of mole of the 
solvate as the size of the alcohol solvent increase.  But with increasing size of the alcohol 
solvent or an increase in the carbon chain of the solvent, the heat of vaporization of the 
alcohol also increased.  Therefore, the heat of vaporization of the alcohol present in the 
solvated form played a large role in determining the differences in the heat of solutions of 
the dihydrated versus solvated form.  This implied that the dihydrated species was be 
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stable across a larger temperature range as the size of the alcohol solvent increased.  
More importantly it implied that the solvated form was less stable as the size of the 
alcohol solvent present in the crystal structure increased. 
5.2 Conclusions 
 
 It was shown using thermodynamic cycles that based on the heats of solution of 
the dihydrated and alcohol solvated forms of sodium naproxen, the dihydrate was stable 
at higher temperatures while the alcohol solvate was stable at lower temperatures.  This 
supported the data presented in chapter 4 related to the transitions of pseudopolymorphic 
forms of sodium naproxen in mixed alcohol-water systems.   
 Additionally, this approach gave insight into the stability of other alcohol solvates 
of sodium naproxen and other pseudopolymorphs.  It showed that as the size of the 
alcohol increased its likelihood to form stabile alcohol solvates decreased as the stability 
of the dihydrated form of sodium naproxen dominated across a wider temperature range.  
This will be explored in later chapters of this work. 
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CHAPTER 6  
CHARACTERIZATION OF A NOVEL METHANOL SOLVATE 
 
Sodium naproxen is a non-steroidal, anti-inflammatory drug that has been shown 
to exhibit four pseudopolymorphic forms (anhydrous, monohydrated, dihydrated, and 
tetrahydrated).  These anhydrate and hydrated species have been thoroughly 
characterized in the literature as shown in Chapter 2, but a recently discovered solvated, 
non-hydrated form of sodium naproxen has not yet been explored.  Characterization of 
the solvate, including determination of the crystal structure and the interaction between 
the solvent and non-solvated crystal molecules, is important for understanding, 
explaining, and predicting the behavior of the solvate during processing.  
Although methanol is not used in the production of sodium naproxen, the use of 
an inert aromatic hydrocarbon solvent, specifically toluene, has been documented to 
produce a more pure chiral product (Phan and Robert, 1997).  No solvate formation is 
seen with the toluene solvent, but understanding solvate formation with other solvents 
could aid in the selection of suitable solvents for various processing aspects. 
Using a batch cooling crystallization process with anhydrous sodium naproxen 
dissolved in methanol solutions, a solvated form was produced.  The present study 
examined this novel methanol solvate of sodium naproxen using powder X-ray 
diffraction, thermogravimetric analysis, differential scanning calorimetry, and nuclear 
magnetic resonance for characterization.  These methods can be used to determine key 
characteristics, such as dehydration enthalpies. A thorough understanding of the 
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characteristics of the methanol solvate of sodium naproxen will aid in understanding and 
predicting the behavior of sodium naproxen in mixed solvent systems with methanol. 
6.1 Experimental Section 
6.1.1 Materials 
The sodium naproxen used in the experiments was provided by Albemarle Corp., 
and was used without further processing or purification.  The methanol solvate crystals 
were produced through batch cooling crystallization; approximately 5 g of sodium 
naproxen was dissolved in approximately 15 g of pure methanol at 10°C, ensuring that 
crystals were still present in the solution.  The solution was placed in an equilibrium cell 
as described in Chapter 3.  The HPLC-grade methanol (purchased from Fisher Scientific) 
was dried overnight using molecular sieves.  The solution was then heated to 55°C, 
thereby dissolving the crystals and forming an unsaturated solution.  The solution was 
then cooled to 10°C, at an approximate cooling rate of 0.6°C per minute, for the 
crystallization of the methanol solvate of sodium naproxen to occur.  Upon crystallization 
the, solution remained at 10°C for at least 18 hours to ensure equilibrium was reached.  
The slurry mixture was then vacuum filtered and the crystals allowed to dry overnight to 
ensure excess solvent on the surface of the crystals was removed.  The resulting crystals 
used for further analysis after being finely ground using a mortar and pestle. 
6.1.2 Thermogravimetric Analysis (TGA) 
Mass loss of the methanol solvate of sodium naproxen was measured using a 
TG/DTA 320 instrument manufactured by Seiko Instrument Inc.  Crystal samples of 10 
to 15 mg were heated from 22°C to 130°C in aluminum pans that were 5 mm in diameter.  
 109
A ramping rate of 10°C/min was used with a nitrogen purge rate of 90 mL/min.  As 
recommended by Di Martino et al (2001), all TGA runs were carried out with open pans 
to ensure proper desolvation of the crystals. 
6.1.3 Differential Scanning Calorimetry (DSC) 
Desolvation endotherms were measured using a DSC 220C instrument (Seiko 
Instrument Inc.) The temperature range of the experiments was 22 to 290°C with a 
heating rate of 10°C/min and a nitrogen purge rate of 90 mL/min.  Crystal samples of 10 
to 15 mg were placed in open aluminum pans with a diameter of 7 mm.  The use of open 
aluminum pans was necessary to obtain quantitative evaluations of the desolvation 
energy (DiMartino et al., 2001). 
6.1.4 Polarized Light Microscopy (PLM)   
Analysis of crystal samples was performed under a Leica DM LM microscope 
equipped with a Sony DKS-5000 digital camera and an objective lens of 20X.  The 
microscope was equipped with a Sony DKC-5000 digital camera that converted the 
focused light into a digital signal, which was then visualized by Image-Pro Plus version 
4.5. 
6.1.5 Nuclear Magnetic Resonance (NMR)   
Crystal samples were dissolved in deuterated water and the liquid sample was 
analyzed using 1H-NMR at 400 MHz and room temperature.  A Varian Mercury Vx 400 
with a 5 mm broadband probe head with 1H decoupling was used to obtain the NMR 
analysis with an acquisition time of 2 seconds and a total run time of 50 seconds. 
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6.1.6 Powder X-ray Diffraction (PXRD) 
Crystals of solvated sodium naproxen were analyzed using PXRD analysis.  A 
PANanlystical X-Pert Pro Alpha-1 diffractometer with copper Kα1 radiation was used in 
conjunction with the X’Celerator detector.  Crystal samples were gently ground to a fine 
powder prior to analysis.  The PXRD pattern was made over a diffraction-angle (2θ) 
range of 10° to 80°, with a step size of 0.02° and a counting time of 1 second per step. 
6.1.7 Fourier Transfer Infrared Spectroscopy (FTIR) 
Fourier Transfer Infrared spectroscopy was performed on a Nicolet Company 
4700 FT-IR Diamond with an optical resolution of 0.4 cm-1 using solid crystal samples 
after drying.  The wavenumber range for sample collection was approximately 4000 to 
400 cm-1.  Data acquisition and processing was performed using a computer with 
Analytical OMNIC software. 
6.2 Results and Discussion 
6.2.1 Thermal and Chemical Analysis of the Samples 
The theoretical solvent content of the methanol solvate form of sodium naproxen 
was 11.258 wt%.  Analysis of TGA data provided results that were close to the expected 
value:  11.240 ± 1.715 (mean ± SD) wt%, based on four runs. Typical data are shown in 
Figure 6.1.  The measured weight loss was similar to that of water loss from dihydrated 
sodium naproxen, 12.499 wt%, but upon further analysis of the TGA curves a difference 
in the dehydration process was observed.  As illustrated the dehydration of dihydrated 
sodium naproxen gave two observable dehydration steps in the TGA curves (Kim and 
Rousseau, 2004), which are Figure 6.1, thought to correspond to the release of two water 
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molecules per mole of sodium naproxen. In contrast, only one step was observable in the 
derivative of the TGA curve (dTGA) for the methanol solvate form, and this step 
corresponds to the release of the single methanol molecule.   
Note that the mass loss from the methanol solvated form began at approximately 
40°C and then started to diminish at approximately 90°C.  This is in contrast to the onset 
of mass loss for the hydrated forms of sodium naproxen, which began almost 
immediately at room temperature (Kim and Rousseau, 2004).  
This analysis was what first led to the discovery of the methanol solvate form.  
Since a solvated form of sodium naproxen had not been previously observed, it was 
initially suspected that the form was merely a dihydrated sodium naproxen due to the 
similar overall mass loss.  Upon further examination of the thermogram the mechanism 
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Figure 6.1.  Thermogravimetic analysis curves and derivatives of the thermogravimetric 
analysis curves of mass loss of methanol solvate and dihydrated sodium naproxen. 
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The DSC analysis was carried out in open pans to avoid any limitations in 
evaporation due to the cover lid (DiMartino et al., 2001).  The results gave a heat of 
desolvation, based on the initial mass of the sample, of 203.6 ± 1.4 J/g for three runs.  
This value was similar to the reported heat of dehydration of the monohydrated sodium 
naproxen, 207.3 J/g; however, it was significantly lower than the heat of dehydration of 
the dihydrated sodium naproxen, 376.8 J/g (Kim and Rousseau, 2004).  If the anhydrous 
species was used as the basis for desolvation and dehydration, the heat of desolvation 
became 229.5 J/g for the solvate.  The heat of dehydration for the monohydrate based on 
the anhydrate was 220.5 J/g.  Assuming this value of the heat of dehydration for the 
monohydrate was equal to that for the second water leaving the dihydrate, it can be 
subtracted from the total heat of dehydration of the dihydrate to determine the heat of 
dehydration required for the removal of the first water molecule.  This would mean the 
heat of dehydration for the first water molecule based on the mass of the anhydrate was 
207.1 J/g (Kim and Rousseau, 2004).  While a summary of the heats of 
desolvation/dehydration is given in Table 6.1, we note that the dehydration energies of 
tetrahydrated sodium naproxen have not been reported (DiMartino et al., 2007).   
There was less than a 10% difference between the heats of dehydration and the 
heat for methanol removal, which implied that the interactions between the molecules of 
the water atoms with the surrounding atoms are energetically similar to the interactions of 
the methanol atom with the surrounding atoms.  The reason for the slightly greater heat of 
solvation was possibly due to the size of the methanol molecule in comparison to that of a 
water molecule.  It has been shown that the dehydration of sodium naproxen occurs 
through channels (Kim and Rousseau, 2004); hence, it would require more energy for a 
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larger molecule, such as methanol, to move through the channels than a smaller molecule, 
compared to water. 
 
 


















Solvate 203.6 229.5 229.5 --- 
Monohydrate 207.3 220.5 220.5 --- 
Dihydrate 376.8 427.6 207.1 220.5 




The heat of desolvation can also be expressed as 1802 J/g methanol.  One can 
then compare this value with the heat of vaporization for methanol, 1096 J/g methanol, 
(Yaws, 2003) at 65°C where the desolvation endotherms reaches its maximum.  With a 
difference of 706 J/g solvent, it was apparent that the methanol was not merely 
evaporating from the crystal structure and there was some molecular interactions of the 
methanol with the sodium naproxen.  The difference in energy between vaporization and 
desolvation for the methanol solvated form was similar to that of water for the 
monohydrate form 764 J/g solvent.   This could have been another indication that the 
interactions of the methanol molecule with sodium naproxen in the alcohol solvated form 
were similar to that of the water molecule in the monohydrate form of sodium naproxen. 
Because the mass loss of the methanol solvate of sodium naproxen was 
approximately that of the dihydrated sodium naproxen, solution 1H-NMR was performed 
to ensure that methanol was present in the solid samples and that water from the 
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atmosphere or other extraneous source was not adsorbing onto the crystal. The resulting 
spectra are given in Figure 6.2 and Figure 6.3.  The upper spectrum was of a sample 
prepared with the methanol solvate of sodium naproxen, and it shows a methanol peak at 
approximately 3.2 ppm.  Each of the remaining peaks are labeled according to the 
chemical structure present in the figure.  The peak at 5.67 ppm was that of the solvent. 
In order to ensure that methanol was present in the crystal structure and not 
merely on the surfaces of the crystal, a similar 1H-NMR analysis was performed on a 
solution prepared with sodium naproxen crystals prepared in methanol, but at an 
equilibrium temperature where the solvate was not formed. (Using the previously 
described procedure, non-solvated crystals have been found to result if the equilibrium 
crystallization temperature was greater than 40°C.) As can be seen in Figure 6.2 and 
Figure 6.3, the NMR spectrum of the non-methanol solvate form was identical to that of 
the methanol solvate of sodium naproxen except for the absence of the methanol peak.  
This showed that any residual methanol that remained on the surface of the crystals after 
filtration was insufficient to show up in the NMR spectrum, which provides further 





























The PXRD pattern of the methanol solvate of sodium naproxen is shown in 
Figure 6.4.  This spectrum differed in peak positions and intensities from the PXRD 
patterns of the previously known pseudopolymorphs of sodium naproxen (anhydrate, 
monohydrate, and dihydrate) reported in literature (DiMartino et al., 2007; Kim and 
Rousseau, 2004), confirming that this novel pseudopolymorph was a distinct crystalline 
species.  Comparison to the tetrahydrated form of sodium naproxen was not possible, 
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 FTIR results can be seen in Figure 6.5.  A broad stretch was seen at a 
wavenumber of 3348.6 cm-1.  Typically stretches between 3600-3200 cm-1 are associated 
with an O-H from alcohols.  More specifically, a sharp, weak stretch from 3600-3500  
cm-1 is indicative of a “free” or unassociated O-H group, while broad stretches in the 
3400-3200 cm-1 range indicate hydrogen bonding from associated O-H groups.  Based on 
the FTIR spectrum it was clear that there was some interaction of the methanol in the 







Figure 6.5. FTIR spectrum of methanol solvated form of sodium naproxen. 
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6.2.2 Crystal Habit 
The crystal habits of the anhydrate, monohydrate, and dihydrate of sodium 
naproxen have been investigated previously (Kim and Rousseau, 2004; DiMartino et al., 
2001) and are shown in Figure 6.6 along with crystals of the methanol solvate of sodium 
naproxen.  The shape of the tetrahydrated form of sodium naproxen has not been reported 
and thus was not presented here. 
Anhydrous sodium naproxen exhibited a needle-like shape that was similar to that 
of the dihydrated pseudopolymorph.  The needle-like crystals of the dihydrated sodium 
naproxen were thinner and smaller than the anhydrate crystals.  Monohydrated crystals 
were less needle-like and formed plate-like crystal structures that were also considerably 
larger than crystals of the anyhydrate and dihydrate of sodium naproxen.  The precise 
shape of the methanol solvate of sodium naproxen was difficult to characterize; the edges 
of the crystals were not well defined in the photomicrographs that were taken, and the 










Figure 6.6. Photomicrographs of (a) anyhydrate, (b) monohydrate, (c) dihydrate, and (d) 






Further characterization of the methanol solvated form of sodium naproxen was 
presented is this chapter.  While the methanol solvated form showed similar mass loss to 
the dihydrated form of sodium naproxen, it was shown to desolvate in one step as 
opposed to two, which initially led to its discovery.  Further analysis by 1H-NMR showed 
that methanol was indeed in the crystal structure due to that fact that a methanol peak was 
observed when a methanol solvated form is grown from equilibrium conditions at 10°C 
in pure methanol, while no methanol peak it observed for anhydrate sodium naproxen 
crystals grown through the same procedure at 40°C.  Characterization of the methanol 
solvated form of sodium naproxen additionally showed that the energy of desolvation for 
the methanol solvated form was slightly greater than that of the monohydrate in terms of 
J/g anhydrate.  The energy of desolvation also showed that methanol was indeed in the 
crystal structure since the desolvation endotherm in terms of moles of alcohol was greater 
than the heat of vaporization of pure methanol at the desolvation temperature, so the 
methanol was not merely on the surface of the crystal.   
Additionally, the PXRD pattern of the methanol solvated sodium naproxen was 
distinct from the other report PXRD patterns, showing it was a discrete crystal species.  
Finally the crystal habit of sodium naproxen was compared to that of the anhydrate, 
monohydrate, and dihydrate forms through PLM imaging.  Methanol solvated crystals of 
sodium naproxen appear to be prism-like in shape, and are small compared to the sizes of 
the other pseudopolymorphs of sodium naproxen.  In conclusion, a novel 
pseudopolymorphic form of sodium naproxen was discovered and characterized by TGA, 
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CHAPTER 7  
CRYSTAL STRUCTURE OF A METHANOL SOLVATE OF 
SODIUM NAPROXEN 
 
Crystal structures provide important information needed to understand the 
chemical and physical properties of organic compounds.  When hydrates and solvates are 
formed, the crystal structures provide insight into the differences between 
pseudopolymorphic states that can result from processing steps, such as crystallization, 
lyophilization, wet granulation, spray-drying, or storage in humid environments 
(Khankari and Grant, 1995).  Knowing crystal structures can help prevent or predict 
possible transformations of pseudopolymorphic forms. 
The structures of naproxen (Ravikumar et al., 1985) and sodium naproxen (Kim et 
al, 2004) have been determined, as well as the structure of the monohydrated form (Kim 
et al., 1990).  The present work was done to (a) determine the structure of the methanol 
solvated form of sodium naproxen and (b) how it relates to other known 
pseudopolymorphic forms.  
7.1 Crystal Growth 
Sodium naproxen supplied by Albemarle Corp. was used without further 
purification to obtain the crystals studied.  Single crystals of the methanol solvate from of 
sodium naproxen were prepared by slow evaporation of a saturated solution of sodium 
naproxen in methanol at 4°C as shown in the Figure 7.1.  The apparatus was placed in an 
enclosure containing desiccants, but was also open to the atmosphere using parafilm with 
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small holes to allow evaporation.  The desiccants were used to prevent water from 








7.2.1 Single Crystal X-Ray Diffraction 
The crystal was analyzed using a single crystal Bruker APEX II CCD 
diffractometer.  The instrument has a sealed Copper x-ray tube with an Oxford 
Cryostream low temperature system and was controlled by PC’s running the Bruker 
APEX2 suite of programs. The instrument used a Monocap X-ray beam intensifier. 
7.2.2 Software 
Visualization of the packing in the methanol solvate crystal was done using the 
Mercury® CSD 2.2 for Windows®.  This software was also used to compute a powder x-
ray diffraction pattern using the single crystal structure. 
Slow Evaporation Slow Evaporation 
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7.3 Results and Discussion 
 
The asymmetric unit of methanol solvated sodium contained two independent 
sodium naproxen molecules and 3 independent methanol molecules as shown in Figure 
7.2.  These data conflicted with the data presented in the previous chapter which seemed 
to show a one-to-one ratio of anhydrous sodium naproxen to methanol in the solvated 




Figure 7.2. A perspective drawing of methanol solvated sodium naproxen with 3 












7.3.1 Single Crystal Analysis 
There was some disorder in the second molecule (B) as evidenced by the enlarged 
thermal ellipsoids shown in Figure 7.2.  The crystal structure provided no obvious 
explanation for this. 
 There were three single bonds in each of the two sodium naproxen molecules 
present in the methanol solvated form of sodium naproxen, C1-O3, C6-C11, and C11-
C12 in the first molecule and C1B-O3B, C6B-C11B, and C11B-C12B for the second 
molecule.  Newman projections around these three bonds are shown in Figure 7.3.  Little 
differences were seen along the C1-O3 bonds between the two molecules, but large 
differences were apparent along the other bonds between the respective pairs of 
molecules.  Significant differences between the torsion angles C7-C6-C11-C12 (-
29.5(6)°) and C7B-C6B-C11B-C12-B (172.7(6)°) were seen as shown in Figure 7.3 (c) 
and Figure 7.3 (d), respectively.  The same was true for the torsion angles C13-C11-C12-
O1 (-30.5(7)°) and C13B-C11B-C12B-O1B (112.2(6)°), which can be seen in Figure 7.3 
(e) and Figure 7.3 (f),respectively.  The differences in the torsions angles were most 
likely due to the interactions between the carboxyl oxygen and sodium, which interactied 
with the oxygen on the methanol group. 
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Figure 7.3. Newman projections of methanol solvated sodium naproxen along the bond of 
(a) C1-C11, (b) C1B-C11B, (c)C6-C11, (d)C6B-C11B, (e) C11-C12, and (f) C11B-
C12B. 
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The methoxy groups in each of the molecules was essentially coplanar with the 
naphthyl ring which gave rise to a narrowing of the O3-C1-C10 and O3B-C1B-C10B, 
angles and an enlargement of the C2-C1-O3 and C2B-C1B-O3B angles.  Domaino et al. 
(1979) previously reported a similar effect and attributed it to some degree of conjugation 
between the oxygen in the methoxy group and the benzene ring, which also gave rise to 
shortening of the C-O bond. 
 
 









The molecular geometry of the methanol solvate of sodium naproxen can be 
compared to that of both the anhydrous material (Kim et al., 2004) and the monohydrate 
material (Kim et al., 1990).  The bond lengths and angles of the methoxy group of the 
methanol solvated form were similar to those in the monohydrate and anhydrate form.  
But when looking at the torsion angles, there were small differences.  Surprisingly, the 
torsion angle for the methoxy group in the solvated species (C2-O3-C1-C14 = -5.4(8)°, 
C2B-O3B-C1B-C14B = -7.8(9)°) was similar to that of the anhydrous material (-7.4(5)° 
and -5.2(5)°) and slightly larger than that of the monohydrate material (-4.1°). 
The anhydrous, monohydrated, and methanol solvated salts crystallized in space 
group P21.  In order to compare to the crystal volumes, the volume of the monohydrate 
was doubled since Z’ = 2 for this material, while Z’ = 4 for the anhydrous material and the 
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methanol solvated material.  The unit volume of the methanol solvated salt was 28.1% 
larger than the anhydrate material, and 15.8% larger than double the unit volume of the 
monohydrate material.  Changes in packing and crystal volume, from the methanol 
solvate to the anhydrous form, are attributed to the removal of the solvent from the 
crystal structure and the subsequent rearrangement to form sodium coordination.  The 
increased size of the methanol solvate compared to the monohydrate was attributed to the 
size difference of the solvent molecules, methanol versus water. 
Three-dimensional packing diagrams along the three axes of the crystal structure 
are shown in Figure 7.4.  Hydrogen bonding is shown in dotted red lines in Figure 7.4.  It 
was these hydrogen bonds that provide stability for the solvated crystal, just as they were 
the dominating force for stability in the monohydrated crystal.  Additionally, the oxygen 
atoms from the methanol solvent in the crystal structures coordinated around the sodium 
ions of the sodium naproxen.  The sodium atom from the first sodium naproxen molecule 
coordinated with seven oxygen atoms either from the carboxyl groups or from the 
solvent; O1, O2, two O1Bi, ii, O2Bii, O2Siii, and O3Siv. The second sodium atom 
coordinated with only six oxygen atoms; O1v, O1Bvi, O2Biii, O1Siii, O2Si and O3Svii.  
These coordinations are presented in an enlarged view of the packing diagram shown in 
Figure 7.5.   These interactions were compared to similar Na-O interactions presents in 
the anhydrous and monohydrate from of sodium naproxen in Table 7.2.  This 
coordination was similar to the coordination seen in monohydrates sodium naproxen as 
shown by Kim et al. (2004) with an additional coordination on the first sodium atom. 
 
                                                 
Symmetry codes: (i) -x+1, y+1, z-1, (ii) x-1, y-1, z+1, (iii) x, y-1, z, (iv) x-1, y-1, z, (v) –x+1, y+1/2, -z+1, 












Figure 7.4. Packing diagrams along (a) the a-axis, (b) the b-axis, and (c) the c-axis of the 
methanol solvate of sodium naproxen.  Sodium atoms are depicted in blue, oxygen atoms 
in red, carbon atoms in gray, and hydrogen atoms in light blue. 
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Table 7.2. Comparison of distances between Na and O by Na-O interactions of 
anhydrous (Kim et al., 2004), monohydrate (Kim et al., 1990) and methanol solvate of 
sodium naproxen. 
 































aThe anhydrate and methanol solvate have two independent sodium atoms in each 
unit cell. 
 bBond Distances are between a sodium cation and oxygen atoms in three different 
carboxyl groups. 






Table 7.3 shows a summary of the crystallographic data and structure refinements for the 
methanol solvate of sodium naproxen.  
7.3.2 Comparison of Crystals made by Cooling versus Slow Evaporation 
Analysis of the single crystal prepared by slow evaporation illustrated a 2:3 
sodium naproxen to methanol ratio, or a 1.5 solvate, while that of the powder samples, 
prepared by slow cooling crystallization, had a 1:1 ratio of sodium naproxen to methanol 
under TGA analysis.  In order to determine if the crystals were distinct, a powder x-ray 
diffraction pattern was simulated from the single crystal data, and measured from crystals 
prepared through slow evaporation  Figure 7.6 shows the simulated PXRD pattern 
compared to the PXRD pattern from the crystals prepared according to chapter 6 and 
those seen in the solubility experiments, as well as a PXRD pattern of crystals prepared 
by slow evaporation and then ground into a fine powder.   The two measured patterns, 
Figure 7.6 (b) and (c), which are shown as mirror-images for comparison reasons, 
appeared to be similar, with only small differences in peaks and peak intensities, which 
were most likely due to differences in packing of the samples.  The samples were top-
packed and were prepared by different users.  Additionally needle-like crystals, like the 
ones studied here, had some affinity for alignment, which could have distorted PXRD 
patterns which assume a random orientation of crystals.  The simulated single crystal 
PXRD (Figure 7.6 (a)) indicated peaks around a Bragg’s angle of 14° which were not 
apparent in the PXRD taken from the other samples.  This indicated that a significant 
amount of the 2:3 ratio solvate was not present in the powder sample.  Additionally, the 






Table 7.3. Crystal data and structure refinements. 
 
Empirical Formula C15.5H19NaO4.5 
Formula Weight 300.30 
Temperature 173(2) K 
Wavelength 1.54178 Å 
Crystal System Monoclinic 
Space Group P2(1) 
Unit Cell Dimensions 
a = 12.7203(3) Å 
b = 7.9897(2) Å 
c = 15.2523(4) Å 
α = 90° 
β = 95.3740(10)° 
γ = 90° 
Volume 1543.30(7) Å3 
Z’ 4 
Density (calculated) 1.292 Mg.m3 
Absorption Coefficient 1.014 mm-1 
F(000) 636 
Crystal Size 0.22 x 0.21 x 0.16 mm3 
θ Range for Data Collection 2.91 to 66.64° 
Index Range -14 <=h<=15, -9<=k<=8, -16<=l<=16
Reflections Collected 11006 
Independent Reflections 4203 [R(int) = 0.0223] 
Completemess to θ = 66.64° 88.1% 
Absorption Correction Semi-Empirical from Equivalents 
Max. And Min. Transmissions 0.8545 and 0.8076 
Refinement Method Full-Matrix Least-Squares on F2 
Data/Restraint/Parameters 4203/26/386 
Goodness-of-Fit- on F2 1.047 
Final R Indices [I>2σ(I)] R1 = 0.0627, wR2 = 0.1687 
R Indices (All Data) R1 = 0.0661, wR2 = 0.1731 
Absolute Structure Parameters 0.19(12) 




















Figure 7.6. (a) Simulated PXRD pattern from single crystal with 2:3 ratio of sodium 
naproxen to methanol, (b) measured PXRD pattern of 1:1 sodium naproxen to methanol 
from cooling crystallization, (c) measured PXRD pattern from slow evaporation 
crystallization . 
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Based on this analysis, it was assumed that the 1.5 solvate, as measured by single 
crystal x-ray diffraction, was not a true representation of the sample.  Selection of the 
crystal was not based on how well it represented the overall sample, but on how well a 
single crystal XRD pattern can be obtained.  It was possible that the crystal selected was 
merely one of a few present in the sample which contained a majority of C14H13NaO3-
·CH3OH solvates. 
Although the crystals were different, analysis of the C14H13NaO3·1.5CH3OH 
single crystal structure and packing arrangement can give insight to how methanol 
molecules are arranged and bonded in the C14H13NaO3·CH3OH molecule.  Similar 
hydrogen bonding and Na-O coordination would be expected in the 1:1 ratio methanol 
solvate compared to those present in the 2:3 ratio methanol solvate. Comparisons can also 
be made to known structures of anhydrous sodium naproxen and monohydrated sodium 
naproxen.  For example the 1:1 methanol solvate would be expected to have a larger unit 
volume than the monohydrate due to the size of the methanol solvent. 
7.4 Conclusions 
 A single crystal of a methanol solvate of sodium naproxen was characterized 
using x-ray diffraction.  This solvate had a chemical formula of C14H13NaO3·1.5CH3OH, 
which was not the expected 1:1 ratio of sodium naproxen to methanol as indicted by 
previous results from slow cooling crystallization.  Although different from the expected 
crystal, the structure of the 1.5 solvate gave insight into bonding and coordination in a 
possible C14H13NaO3·CH3OH solvate.  The 1.5 solvate showed similar hydrogen boding 
and Na-O coordination to the monohydrate species, with hydrogen bonding being the 
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dominate force in solvate formation.  An increase in unit volume was also observed most 
likely due to the inclusion of a larger number of solvent molecules in the crystal structure. 
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CHAPTER 8  
ORGANIC ALCOHOL SOLVATES OF SODIUM NAPROXEN 
 
 Growing organic crystals from solution can allow incorporation of the solvent 
into the crystal lattice.  Inclusion of this solvent has three functions: (1) participating in 
hydrogen-bonding networks, (2) filling space in the unit cell, with no strong interactions 
between solute and solvent molecules, and (3) facilitating closest packing arrangements. 
(Görbitz and Hersleth, 2000; Myrdal and Jozwiakowski, 2000).  Whether a solvent 
exhibits one or all of these functions, its incorporation into the crystal structure is 
important for determining the physical properties of the solvate. 
 Identification of structures with organic solvent molecules incorporated in the 
crystal lattice is steadily increasing.  A search of the Cambridge Structural Database in 
November 2006 revealed that there are 85,316 compounds that are known to form 
solvates (including hydrates) with the 51 most common solvents, (van de Streek, 2007). 
Clearly it is important to consider the possibilities of solvent inclusion in crystallization 
experiments.  Additionally, for many compounds the presence of solvents is needed for 
successful crystallization outcomes.  For example, structures with cavities or empty 
channels are generally unstable and occasionally crystals may not be obtained if the 
structure of solute molecules is not supported by carefully selected solvent molecules 
(Kitaigorodski, 1961). 
Previous studies of sodium naproxen have focused on hydrate formations and the 
solid-state transformations associated with them, but none have looked at the ability to 
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form alcohol solvates (DiMartino et al., 2007; DiMartino et al., 2001; Kim and Rousseau, 
2004; Kim et al., 1990).  In this chapter, the role of organic alcohol solvents and their 
ability to form solvates with sodium naproxen under batch cooling crystallization was 
examined. The study analyzed these novel organic alcohol solvates of sodium naproxen 
using thermogravimetric analysis, differential scanning calorimetry, polarized light 
microscopy, 1H-nuclear magnetic resonance, and powder X-ray diffraction for 
characterization.  Moving beyond the fact that these solvates exist, the work provided 
insight to the role size and shape of alcohol molecules play in the ability of sodium 
naproxen to solvate.   
8.1 Experimental Section 
8.1.1 Materials   
Sodium naproxen was provided by Albemarle Corp., and was used without 
further processing or purification.  The following alcohols were purchased from VWR 
Inc.:  low-water 2-propanol, ACS Grade 99.5% 1-propanol, 99.4% min. 1-butanol, and 
HPLC grade isobutanol.  Each alcohol was dried overnight using 3Å molecular sieves to 
remove water.  The solvated crystals were produced through batch cooling 
crystallization; approximately 5 g of sodium naproxen was dissolved in approximately 15 
g of alcohol at 10°C in an equilibrium cell.  Approximately 2 g of sodium naproxen was 
added until a slurry solution was achieved and sodium naproxen no longer dissolved.  
The solution was then heated until all the crystals dissolved as determined by visible 
inspection.  The solution was then cooled to 10°C, at an approximate rate of 0.6°C per 
minute, for the crystallization of solvated sodium naproxen species to occur.  After 
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allowing the solution to reach equilibrium, as described in Chapter 3, the slurry mixture 
was vacuum filtered and the resulting crystals used for analysis. 
8.1.2 Thermogravimetric Analysis (TGA) 
Mass loss of the sodium naproxen samples was measured using a TG/DTA 320 
instrument manufactured by Seiko Instrument Inc.  Crystal samples of 10 to 15 mg were 
heated from 22°C to 130°C in aluminum pans that were 5 mm in diameter.  A ramping 
rate of 10°C/min was used with a nitrogen purge rate of 90 mL/min.  As recommended 
by Di Martino et al, all TGA runs were carried out with open pans (2001).  
8.1.3 Differential Scanning Calorimetry (DSC) 
Desolvation endotherms were measured using a DSC 220C instrument (Seiko 
Instrument Inc.) The temperature range of the experiments was 22 to 290°C with a 
heating rate of 10°C/min and a nitrogen purge rate of 90 mL/min.  Crystal samples of 10 
to 15 mg were placed in open aluminum pans with a diameter of 7 mm.  The use of open 
aluminum pans was necessary to obtain quantitative evaluations of the desolvation 
energy (DiMartino et al., 2001).  
8.1.4 Polarized Light Microscopy (PLM) 
Analysis of crystal samples was performed under a Leica DM LM microscope 
equipped with a Sony DKS-5000 digital camera and an objective lens of 20X.  The 
microscope was equipped with a Sony DKC-5000 digital camera that converted the 
focused light into a digital signal, which was then visualized by Image-Pro Plus version 
4.5. 
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8.1.5 Nuclear Magnetic Resonance (NMR) 
To determine the solvent in the crystal structures, crystal samples were dissolved 
in deuterated water and the solution samples were analyzed using 1H-NMR at 400 MHz 
and room temperature.  A Varian Mercury Vx 400 with a 5 mm broadband probe head 
with 1H decoupling was used to obtain the NMR analysis with an acquisition time of 2 
seconds and a total run time of 50 seconds. 
8.1.6 Powder X-ray Diffraction (PXRD) 
Crystals of the solvated sodium naproxen were analyzed using PXRD analysis.  A 
PANanlystical X-Pert Pro Alpha-1 diffractometer with copper Kα1 radiation was used in 
conjunction with the X’Celerator detector.  Crystal samples were gently ground to a fine 
powder prior to analysis.  The PXRD pattern was made over a diffraction-angle (2θ) 
range of 10° to 80°, with a step size of 0.02° and a counting time of 1 second per step. 
8.2 Results and Discussion 
8.2.1 Thermal Analysis 
 An example of a typical TGA and DSC for 2-propanol solvate is shown in Figure 
8.1.  This figure is representative of TGA and DSC thermograms for all of the alcohol 
solvates with changes only seen in the final % mass.  Mass loss prior to the melting point 
of sodium naproxen (250°C) was assumed to be a result of desolvation; i.e. removal of 

































Temperature (°C)  
Figure 8.1. Representation of TGA and DSC traces of alcohol solvates. 
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 Based on complete solvent removal mass loss, and the molecular weight of the 




% Mass Loss =
Molar Ratio*Alcohol MW
Molar Ratio*Alcohol MW+Sodium Naproxen MW




Table 8.1 shows the percent mass loss (± one standard deviation, based on 3-4 
independent experiments) and equivalent molar ratio of alcohol to one mole of sodium 
naproxen for each of the alcohol solvents as determined by the TGA: 
 
 
Table 8.1.  TGA mass loss of alcohol solvates. 
Alcohol Ethanol 1-Propanol 2-Propanol 1-Butanol Isobutanol 
% Mass Loss 13.5 ± 0.4 10.4 ± 2 9.0 ± 0.8 9.5 ± 0.7 7.3 ± 0.7 




These percent mass losses may seem small but when compared to mass loss for an 
anhydrated form of sodium naproxen prepared from similar methods, which had less than 
about a 1% mass loss, these amounts were statistically  significant based on standard 
deviations.  These results clearly showed that each of the solvents has been incorporated 
into sodium naproxen crystals. 
 As the size of the alcohol increased, the amount of alcohol present in the crystal 
structure, as represented by the TGA data, decreased on a molar basis.  Additionally, the 
 146
branched alcohols were present in the crystal at smaller molar amounts than the 
unbranched alcohols.  Using the compounds’ densities and molecular weights, their 
molar densities can be calculated and are listed in Table 8.2. 
 
 
Table 8.2.  Molar Densities of Alcohols. 
Alcohol Ethanol 1-Propanol 2-Propanol 1-Butanol Isobutanol
Molar Density 




The molar densities followed the same pattern as the molar amount of alcohol present in 
the solvate structure.  Since molar densities also take into account the structure of the 
molecule, these results indicated that both the length of the carbon chain present in the 
alcohol and the branching of the alcohol affected its ability to solvate with sodium 
naproxen.  Bulkier alcohol molecules would have more difficulty in creating the 
hydrogen bonds necessary to form solvates with sodium naproxen.  Since hydrogen 
bonding has been shown to be the predominate attraction in the hydrates (Kim et al., 
2004) and methanol solvate of sodium naproxen, bulkier molecules would be limited in 
their ability to form similar solvates.  Hence the pattern of decreased alcohol present in 
the solvates as the length of the hydrocarbon chain and branching increases. 
 DSC data were used to show how strongly each solvent is bound in the crystal 
structure and to show that such solvents were not merely on the surface of the crystals.  





Table 8.3.  DSC desolvation energies (± one standard deviation) of alcohol solvates. 














 In order to compare the values across alcohol solvates, the desolvation energies 
were converted to J/g of anhydrous sodium naproxen using the molar ratios determined 
by the TGA and are also listed in the table. 
 In addition, desolvation values were also be converted to J/ g alcohol in the 
solvate and compared to the latent heat of vaporization of the alcohol at a particular 
temperature.  Table 8.4 shows the converted values compared to the latent heat of 
vaporization at 65°C (Yaws, 2003).  This temperature was chosen since it falls 
approximately in the center of the range of temperatures where desolvation occurs. 
 
 
Table 8.4.  Comparison of desolvation energies and latent heats of vaporization. 









39.64 44.82 46.40 47.07 49.67 
Desolvation 
Energy – Heat of 
Vaporization 
(kJ/mole alcohol) 
35 77 84 139 162 
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 The heat of desolvation was greater than the latent heat of vaporization indicating 
that the alcohol was not merely on the surface of the crystal and evaporating.  
Additionally, the difference in desolvation energy and heat of vaporization followed the 
reverse pattern to the TGA data presented earlier.  As the number of carbons in the 
organic alcohol increased and the amount of branching increased, the energy required to 
remove the solvent from the crystal structure also increased. 
 Hydrates have been classified in three ways (Kim and Rousseau, 2004): (1) 
isolated-site hydrates, which show sharp narrow TGA mass losses and DSC endotherms 
upon dehydration, (2) ion-associated hydrates, which display strong metal-water 
interactions and higher dehydration temperatures and molar heats of dehydration, and (3) 
channel hydrates, which have early onset temperatures of dehydration and broader TGA 
and DSC traces. Both monohydrated (Kim and Rousseau, 2004) and dihydrated (Kim et 
al., 1990) sodium naproxen have been shown to lose water by diffusion through channels 
in the crystal.  Figure 8.1 indicates the solvated forms were channel solvates due to both 
the early onset of desolvation with temperature and the broader TGA and DSC traces.   
 The channels would make it more difficult for larger or branched species to 
incorporate into the crystal structure, since larger channels are needed and could cause 
instability.  This explains why as the size of the alcohol increased, the amount of alcohol 
in the solvate decreased.  Additionally, since less alcohol was present the ratio of oxygen 
from the alcohol to sodium from the sodium naproxen was smaller, meaning the Na-O 
coordination would be stronger.  For every oxygen molecule present in the solvate there 
were more sodium molecules available for coordination/bonding.  This would make the 
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bonds stronger.  These stronger bonds clearly illustrate why there was an increase in the 
energy necessary to remove the solvent from the solvated species per mole of alcohol. 
8.2.2 Crystal Shapes 
Figure 8.2 shows photomicrographs which were taken of each of the solvated 
crystals of sodium naproxen.  The solvated crystals of propanol and butanol solvents had 
a needle-like shape similar to that of the anhydrated species, while the ethanol solvated 
species was larger and seemed to have a plate-like shape.  The edges of the ethanol 
crystals were not sharp most likely due to their instability (they began to dissolve into 
solution as the photomicrographs are being taken).  A similar shape was seen with the 




Figure 8.2.. Photomicrographs of (a) ethanol, (b) propanol, (c) 2-propanol, (d) butanol, 




(a) (b) (c) 
(d) (e) 
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According to the photomicrographs, the overall crystal shape was not affected 
when larger solvent molecules were used for cooling crystallization possibly due to the 
fact that a significant amount of the alcohol solvent was not present in the crystal 
structure.  But when smaller molecules were used there was a significant effect on the 
overall crystal shape observed using photomicroscopy. 
8.2.3 Nuclear Magnetic Resonance 
1H-NMR was used to show if the solvent present in the crystals was indeed the 
alcohol.  This method was used previously with the methanol solvated form of sodium 
naproxen (Chavez and Rousseau, 2008) and an additional methanol peak was seen along 
with the peaks associated with sodium naproxen.  But for the current alcohol solvates 
being explored there was no presence of additional peaks corresponding to the alcohol 
solvent, as seen in Figure 8.3-Figure 8.8.  This is most likely due to the concentration of 
the alcohols present in the solution.  Ideally for NMR spectroscopy a solution of a 
concentration range between 5-10 mg/mL is needed. (Jacobsen, 2007)  Due to the low 
solubility of the solvated forms in D2O and the small of amount of alcohol present in the 
crystal as shown through TGA data, there was not enough alcohol present in the 1H-NMR 
sample to be properly detected.  Interesting to note though was the apparent slight 
rearrangement of some the peaks compared to the 1H-NMR spectrum of anhydrous 
sodium naproxen.  This would indicate slight variations in the chemical environments 
between the anhydrated form of sodium naproxen and the solvated forms studied here, 
















































Figure 8.8. 1H-NMR spectrum for isobutanol solvate of sodium naproxen. 
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8.2.4 Powder X-Ray Diffraction 
PXRD was used to determine if the solvated crystals had distinct crystal structures 
and how these structures compared.  As shown in Figure 8.9, the diffractograms were 
similar and only had slight differences with respect to the anhydrous PXRD pattern.  The 
methanol, ethanol, 1-propanol and isobutanol solvated forms exhibited a complete 
absence of the anhydrous peak seen at a 2θ of 13.2°, which was a result from diffraction 
of the (003) plane (Kim et al., 2004).  This showed that no anhydrous material was 
present in these solvated forms.  The 2-propanol and 1-butanol had a peak at 13.0°, which 
was similar to the anhydrous peak, but did not give a clear indication that a mixture was 
present.  A clearer indication of the absence of a mixture can be explained by the absence 
of peaks for the 2-propanol and 1-butanol solvates at a Bragg’s angle of 20.0°, which was 
present in the anhydrous PXRD pattern.  Additional peaks at 12.5°, 12.0°, 11.9°, 12.0°, 
and 12.4° were seen in the ethanol, 1-propanol, 2-propanol, 1-butanol, and isobutanol 
solvated forms, respectively.  An additional peak was also visible around a Bragg’s angle 
of 15.8° for all of the solvated crystals.  This peak was not present in the diffractogram of 
the anhydrous crystals.  Also not present in the anhydrous PXRD scan was a peak at 























Figure 8.9.  PXRD data for solvated crystals of sodium naproxen. 
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These differences showed that the solvent does have an effect on the crystal 
structure, even if only slightly, and they were distinct crystals.  Some of these differences 
could be seen in the photomicrographs of the various solvated crystals as presented 
earlier. 
8.3 Conclusions 
The ability of alcohol solvents to form solvates with sodium naproxen was 
discussed in terms of their size and shape.  Each of the solvates was analyzed using TGA, 
DSC, photomicroscopy, 1H-NMR, and PXRD.  Results showed that each of the crystals 
obtained from cooling crystallization in the pure solvents were distinct and some 
inclusion of the solvent was observed for all of the organic solvents tested.  Additionally 
larger amounts of solvent affected crystal shape, as seen with the ethanol solvated forms.   
The findings presented here mostly impact the solvate formation of channel-type 
solvates, similar to that of sodium naproxen.  The ability of the organic solvents to create 
these channels and be removed from them has a large influence of the data presented here 
relating to the solvents chain length and branching. 
Examining how the size and shape of a solvent can influence crystal growth and 
shape can aid in the understanding of the ability of compounds to form solvates.  And 
with the increasing number of solvates being discovered, this understanding can be useful 
for solvent selection. 
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CHAPTER 9  
CONCLUSIONS AND RECOMMENDATIONS 
 
9.1 Conclusions 
Solubilities of sodium naproxen over an approximate temperature range of 10°C 
to 40°C was measured using high performance liquid chromatography in solutions of 10 
mol%, 25 mol%, 47 mol% methanol-in-water and pure methanol, as well as 14.5 mol%, 
44 mol%, 67 mol%, 79 mol% ethanol-in-water and pure ethanol.  Addition of the organic 
alcohols caused both salting-out and salting-in effects.  At lower concentrations of 
methanol a salting-in effect was observed, while at higher concentrations and with 
ethanol a salting-out effect was evident.  In terms of temperatures, concentration 
increased as temperature increased.  It should be noted that solvent concentration played 
a larger role than temperature in affecting solubilities.  Changes in pseudopolymorphic 
forms were also evident based on solid-state analysis.  The following pseudopolymorphic 
forms were present in the solution and temperature ranges studied in these systems: 
anhydrate, monohydrate, dihydrate, methanol solvate, and ethanol solvate. 
These changes in pseudopolymorphic form were further analyzed using van’t 
Hoff plots (logarithm of solubility versus inverse temperature) to determine the transition 
temperature between the two stable pseudopolymorphs.  Extracting the transition 
temperature, and using the known solvent concentration, the activity of water at the 
transition point was determined.  Using the activity of water at the transition point, it was 
seen that independent of the alcohol concentration, water activity was the same for 
methanol and ethanol solutions at the transition point.  It should be noted that the 
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transition from an alcohol solvated form of sodium naproxen to the dihydrated form was 
evident at two independent water activities.  This work suggested that there are a range of 
water activities where a specific transition will occur, as opposed to only one specific 
water activity. 
Additionally, novel organic alcohol solvates of sodium naproxen were explored.  
The alcohol solvated forms of sodium naproxen, which included a methanol, ethanol, 1-
propanol, 2-propanol, 1-butanol, and isobutanol solvated forms, were characterized using 
a variety of techniques including TGA, DSC, PXRD, 1H-NMR, and PLM imaging.  It 
was shown that the recrystallization of anhydrous sodium naproxen in pure alcohol 
solvents at low temperatures gave rise to solvated crystals.  This was apparent in 1H-
NMR data where there were clear changes in the spectrum compared to the anhydrous 
form.  This indicated some change in atomic interactions.  Furthermore, these techniques 
generally indicated that as the size of the alcohol increased its ability to be included in the 
crystal decreased, as indicated by the TGA studies.  This was due to the bonding ability 
of solvents in sodium naproxen and how these solvents are included in the crystal 
structure.  The channel-like locations of solvents make it difficult for larger molecules to 
allow a stable crystal structure since they inhibit the hydrogen bonding and sodium-
oxygen interactions.  This explanation can be extended to the results from the DSC 
studies.  More energy was required to remove larger molecules from the crystal structure 
than smaller molecules.  Both size and shape of the solvents played a role in its ability to 
form pseudopolymorphs of sodium naproxen. 
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The methanol solvated form of sodium naproxen was the most thoroughly 
explored pseudopolymorph in this work.  Additional studies on the methanol solvate of 
sodium naproxen included IR and, most importantly, a single crystal XRD. 
9.2 Recommendations 
 
Recommendations for future work are listed as follows: (1) follow-up study on 
organic alcohol solvates of sodium naproxen, (2) mechanism for transitions of 
pseudopolymorphs, (3) predictions of pseudopolymorphic transitions. 
(1) A number of organic alcohol solvates were briefly studied in this thesis.  A 
more thorough analysis of these organic solvates is possible.  This would 
include the stability and dissolution studies of these organic solvates and 
comparisons to structural similarities of other pseudopolymorphic forms of 
sodium naproxen.  The ethanol solvated form showed smaller crystal size than 
other pseudopolymorphs of sodium naproxen, which would mean faster 
dissolution and could have some pharmaceutical applications.  Smaller, stable 
crystals can have better packing features and dissolution in patients.  
Understanding how simple recrystallization in an ethanol solvent could help 
obtain such crystals would be useful.  These solvated forms also provide a 
possible simulation study on the crystal structures of the solvates in terms of 
stabilization forces.   
(2) In industrial settings, sudden appearances of unknown pseudopolymorphs or 
polymorphs are important because it often attributes to loss of time and 
money.  To understand the microscopic mechanism of transformation would 
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provide insight into the stability of the polymorphic and pseudopolymorphic 
forms.  Three pseudopolymorphic transitions are seen with sodium naproxen: 
anhydrate to dihydrate, dihydrate to solvate, and dihydrate to monohydrate.  
The study of the microscopic mechanisms of these transitions would be a 
good place to start in studying transitions. 
(3) Initially, this work was carried out in hopes of developing a predictive model 
for pseudopolymorphic transitions.  Due the discovery of solvated forms of 
sodium naproxen, which was a more interesting study, this section was not 
developed.  Having a model to predict the transitions of pseudopolymorphs 
would be very useful in industrial settings for helping to avoid or force 
transitions when it is so desired.  A predictive model, on when 
pseudopolymorphic changes would occur, has not yet been realized but would 
have a large impact on the understanding and possible discovery of 
pseudopolymorphic forms.  More precise modeling of the activity 
coefficients, including that of the dissolved solute, would be an appropriate 






This appendix contains all of the calibration curves from the HPLC experiments 
that were conducted in support of the solubility of sodium naproxen in various solvents.  
Depending on the time the experiments took for a specific concentration, multiple 
calibration curves may have been needed for the same solvent concentration. 
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Figure A.8. Calibration curve for 10 mol% methanol-in-water made on January 2, 2007. 
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Figure A.12. Calibration curve for 47 mol% methanol-in-water made on April 24, 2007. 
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Figure A.13. Calibration curve for pure methanol. 
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Figure A.14. Calibration curve of 14.5 mol% ethanol-in-water. 
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Figure A.15. Calibration curve for 44 mol% ethanol-in-water. 
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Figure A.16. Calibration curve for 67 mol% ethanol-in-water. 
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Figure A.17. Calibration curve for 79 mol% ethanol-in-water. 
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Figure A.19. Calibration curve for pure ethanol made on June 4, 2008.
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APPENDIX B: 




Table B.1. Atomic coordinates (x104) and equivalent isotropic displacement parameters 
(Åx103) for methanol solvate of sodium naproxen. U(eq) defined as one third of the trace 
of the orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________________ 
C(1) 4000(4) -374(6) 4973(3) 39(1) 
C(2) 4659(4) 466(6) 5570(3) 39(1) 
C(3) 4479(3) 465(6) 6495(3) 33(1) 
C(4) 5112(3) 1336(6) 7125(3) 35(1) 
C(5) 4887(3) 1357(6) 7986(3) 32(1) 
C(6) 3998(3) 522(5) 8269(3) 30(1) 
C(7) 3394(3) -390(6) 7650(3) 33(1) 
C(8) 3610(3) -473(6) 6752(3) 37(1) 
C(9) 2976(4) -1381(7) 6111(3) 43(1) 
C(10) 3166(4) -1339(7) 5253(3) 43(1) 
C(11) 3754(3) 646(6) 9213(3) 34(1) 
C(12) 2566(3) 480(5) 9290(3) 29(1) 
C(13) 4390(4) -652(9) 9794(4) 58(2) 
C(14) 4856(5) 658(8) 3752(4) 63(2) 
C(1B) 8065(4) 9188(9) 5029(5) 73(2) 
C(2B) 9007(6) 9845(9) 5081(5) 82(2) 
C(3B) 9640(4) 9558(7) 4265(4) 52(1) 
C(4B) 10630(5) 10120(10) 4273(5) 87(2) 
C(5B) 11109(6) 9795(9) 3523(4) 78(2) 
C(6B) 10652(5) 8860(8) 2785(4) 61(2) 
C(7B) 9671(6) 8294(10) 2800(4) 79(2) 
C(8B) 9081(5) 8650(8) 3621(5) 75(2) 




Table B.1. Continued 
______________________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________________ 
C(10B) 7563(6) 8294(10) 4333(5) 77(2) 
C(11B) 11280(4) 8500(7) 2018(3) 43(1) 
C(12B) 10647(3) 8922(6) 1137(3) 32(1) 
C(13B) 12325(5) 9435(11) 2072(4) 74(2) 
C(14B) 7815(5) 9971(10) 6445(6) 85(2) 
C(1S) 6667(5) 10178(7) 1836(4) 58(2) 
C(2S) 514(5) 8157(8) 7409(4) 52(1) 
C(3S) 7550(4) 9160(9) 8993(4) 64(2) 
Na(1) 311(1) 151(2) 9396(1) 33(1) 
Na(2) 8583(1) 1561(2) 547(1) 36(1) 
O(1) 2197(3) -929(4) 9442(2) 44(1) 
O(2) 2002(2) 1767(4) 9163(2) 41(1) 
O(3) 4078(3) -393(5) 4087(2) 51(1) 
O(1B) 10500(2) 7784(4) 575(2) 37(1) 
O(2B) 10341(3) 10413(4) 1012(2) 37(1) 
O(3B) 7376(4) 9342(7) 5758(3) 77(1) 
O(1S) 7438(3) 9942(4) 1268(3) 66(1) 
O(2S) 40(3) 8289(4) 8185(3) 54(1) 




Table B.2. Bond lengthes (Å) and angles (°) for methanol solvated form of sodium 
naproxen. 
______________________________________________________________________________________  
C(1)-C(2)  1.356(7) 
C(1)-O(3)  1.364(6) 
C(1)-C(10)  1.410(7) 
C(2)-C(3)  1.450(7) 
C(2)-H(2A)  0.9500 
C(3)-C(4)  1.383(6) 
C(3)-C(8)  1.422(6) 
C(4)-C(5)  1.369(6) 
C(4)-H(4A)  0.9500 
C(5)-C(6)  1.415(6) 
C(5)-H(5A)  0.9500 
C(6)-C(7)  1.370(6) 
C(6)-C(11)  1.505(7) 
C(7)-C(8)  1.424(7) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.408(7) 
C(9)-C(10)  1.353(7) 
C(9)-H(9A)  0.9500 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.532(6) 
C(11)-C(13)  1.543(7) 
C(11)-H(11A)  1.0000 
C(12)-O(1)  1.250(5) 
C(12)-O(2)  1.258(5) 
C(12)-Na(1)  2.899(4) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-O(3)  1.429(7) 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(1B)-C(2B)  1.304(9) 
C(1B)-C(10B)  1.385(10) 
C(1B)-O(3B)  1.484(8) 
C(2B)-C(3B)  1.561(9) 
C(2B)-H(2B)  0.9500 
C(3B)-C(4B)  1.335(8) 
C(3B)-C(8B)  1.366(8) 
C(4B)-C(5B)  1.370(9) 
C(4B)-H(4BA)  0.9500 
C(5B)-C(6B)  1.429(9) 
C(5B)-H(5BA)  0.9500 
C(6B)-C(7B)  1.329(9) 
C(6B)-C(11B)  1.505(8) 
C(7B)-C(8B)  1.546(9) 
C(7B)-H(7BA)  0.9500 
C(8B)-C(9B)  1.344(9) 
C(9B)-C(10B)  1.414(10) 
C(9B)-H(9BA)  0.9500 
C(10B)-H(10B)  0.9500 
C(11B)-C(13B)  1.520(9) 
C(11B)-C(12B)  1.538(7) 
C(11B)-H(11B)  1.0000 
C(12B)-O(1B)  1.251(6) 
C(12B)-O(2B)  1.262(5) 
C(12B)-Na(1)#1  2.826(5) 
C(13B)-H(13D)  0.9800 
C(13B)-H(13E)  0.9800 
C(13B)-H(13F)  0.9800 
C(14B)-O(3B)  1.247(9) 
C(14B)-H(14D)  0.9800 
C(14B)-H(14E)  0.9800 
C(14B)-H(14F)  0.9800 
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Table B.2. Continued. 
________________________________________________________________________ 
C(1S)-O(1S)  1.381(6) C(1S)-H(1S1)  0.9800
C(1S)-H(1S2)  0.9800 
C(1S)-H(1S3)  0.9800 
C(2S)-O(2S)  1.381(7) 
C(2S)-H(2S1)  0.9800 
C(2S)-H(2S2)  0.9800 
C(2S)-H(2S3)  0.9800 
C(3S)-O(3S)  1.402(7) 
C(3S)-H(3S1)  0.9800 
C(3S)-H(3S2)  0.9800 
C(3S)-H(3S3)  0.9800 
Na(1)-O(1B)#2  2.346(3) 
Na(1)-O(2S)#3  2.371(4) 
Na(1)-O(2B)#4  2.471(4) 
Na(1)-O(3S)#5  2.496(4) 
Na(1)-O(1)  2.544(4) 
Na(1)-O(2)  2.562(4) 
Na(1)-O(1B)#4  2.606(4) 
Na(1)-C(12B)#4  2.826(5) 
Na(1)-Na(2)#6  3.148(2) 
Na(1)-Na(2)#2  3.192(2) 
Na(2)-O(1)#7  2.237(4) 
Na(2)-O(1S)#3  2.302(4) 
Na(2)-O(1B)#8  2.371(4) 
Na(2)-O(3S)#9  2.394(4) 
Na(2)-O(2B)#3  2.460(4) 
Na(2)-O(2S)#2  2.842(5) 
Na(2)-Na(1)#10  3.148(2) 
Na(2)-Na(1)#7  3.192(2) 
O(1)-Na(2)#2  2.237(4) 
O(1B)-Na(1)#7  2.346(3) 
O(1B)-Na(2)#11  2.371(4) 
O(1B)-Na(1)#1  2.606(4) 
O(2B)-Na(2)#12  2.460(4) 
O(2B)-Na(1)#1  2.471(4) 
O(1S)-Na(2)#12  2.302(4) 
 
O(1S)-H(1SO)  0.9120 
O(2S)-Na(1)#12  2.371(4) 
O(2S)-Na(2)#7  2.842(5) 
O(2S)-H(2SO)  0.8737 
O(3S)-Na(2)#13  2.394(4) 
O(3S)-Na(1)#14  2.496(4) 
































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y+1,z-1    #2 -x+1,y-1/2,-z+1    #3 x,y-1,z       
#4 x-1,y-1,z+1    #5 x-1,y-1,z    #6 x-1,y,z+1       
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Table B.3. Anisotropic displacement parameters (Å2x103) for methanol solvate of sodium 
naproxen, anisotropic displacement factor exponent takes the form: -2π2 [h2 a*2U11+...2 h 
k a*b*U12]. 
______________________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________________  
C(1) 47(3)  35(3) 36(3)  -4(2) 9(2)  -2(2) 
C(2) 40(2)  37(3) 43(3)  7(2) 13(2)  4(2) 
C(3) 27(2)  31(2) 41(3)  4(2) 8(2)  5(2) 
C(4) 33(2)  30(2) 43(3)  4(2) 12(2)  -1(2) 
C(5) 32(2)  33(2) 31(3)  1(2) 5(2)  -3(2) 
C(6) 26(2)  27(2) 36(3)  5(2) 4(2)  5(2) 
C(7) 33(2)  30(2) 36(3)  1(2) 10(2)  -6(2) 
C(8) 35(2)  32(2) 43(3)  3(2) 2(2)  -1(2) 
C(9) 45(3)  40(3) 45(4)  -6(2) 10(2)  -13(2) 
C(10) 44(3)  48(3) 38(3)  -4(2) 6(2)  -7(2) 
C(11) 30(2)  35(2) 36(3)  5(2) 3(2)  1(2) 
C(12) 31(2)  23(2) 34(3)  -2(2) 9(2)  -3(2) 
C(13) 45(3)  79(4) 49(4)  25(3) 0(3)  16(3) 
C(14) 86(4)  64(4) 40(4)  -6(3) 23(3)  -23(3) 
C(1B) 41(3)  81(5) 98(6)  53(5) 13(3)  -1(3) 
C(2B) 105(6)  64(5) 72(5)  11(4) -14(4)  11(4) 
C(3B) 59(3)  43(3) 52(4)  5(3) -11(3)  -4(3) 
C(4B) 80(5)  74(5) 101(6)  21(5) -30(4)  -12(4) 
C(5B) 132(6)  73(5) 33(4)  7(3) 28(4)  34(4) 
C(6B) 75(4)  61(4) 48(4)  22(3) 12(3)  29(3) 
C(7B) 85(5)  111(6) 46(4)  34(4) 27(4)  35(5) 
C(8B) 59(4)  43(3) 116(6)  6(4) -27(4)  -4(3) 
C(9B) 103(6)  74(5) 91(6)  12(4) -33(5)  -21(5) 
C(10B) 93(5)  78(5) 63(5)  4(4) 31(4)  -7(4) 
C(11B) 56(3)  49(3) 25(3)  4(2) 10(2)  14(3) 
C(12B) 37(2)  27(2) 33(3)  -1(2) 9(2)  -2(2) 
C(13B) 61(4)  96(5) 61(4)  10(4) -14(3)  4(4) 
C(14B) 45(3)  74(5) 132(7)  -3(5) -14(4)  -4(3) 
C(1S) 74(4)  40(3) 66(4)  -10(3) 34(3)  -11(3) 
C(2S) 63(3)  51(3) 45(4)  -5(3) 12(3)  -20(3) 
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Table B.3. Continued. 
______________________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________________  
C(3S) 49(3)  73(4) 69(4)  14(4) -6(3)  -12(3) 
Na(1) 34(1)  27(1) 37(1)  -1(1) 7(1)  5(1) 
Na(2) 39(1)  24(1) 47(1)  3(1) 17(1)  1(1) 
O(1) 43(2)  31(2) 59(2)  5(2) 19(2)  -6(2) 
O(2) 39(2)  28(2) 57(2)  -3(2) 11(2)  5(2) 
O(3) 65(2)  51(2) 39(2)  -7(2) 13(2)  -7(2) 
O(1B) 42(2)  26(2) 43(2)  -5(2) 11(2)  -3(1) 
O(2B) 51(2)  26(2) 35(2)  -2(1) 3(1)  7(2) 
O(3B) 70(3)  96(4) 66(3)  4(3) 10(2)  18(3) 
O(1S) 81(3)  28(2) 98(4)  -5(2) 56(3)  -11(2) 
O(2S) 82(3)  36(2) 47(2)  -5(2) 25(2)  -22(2) 




Table B.4. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 
103) for methanol solvated form of sodium naproxen. 
______________________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________________  
H(2A) 5243 1061 5380 47 
H(4A) 5710 1928 6959 42 
H(5A) 5343 1950 8406 38 
H(7A) 2806 -993 7828 39 
H(9A) 2407 -2034 6284 52 
H(10A) 2731 -1968 4834 52 
H(11A) 3976 1784 9432 41 
H(13A) 5145 -505 9736 87 
H(13B) 4174 -1783 9604 87 
H(13C) 4254 -492 10410 87 
H(14A) 4834 519 3112 94 
H(14B) 5557 348 4024 94 
H(14C) 4711 1829 3889 94 
H(2B) 9289 10459 5582 98 
H(4BA) 10975 10701 4761 105 
H(5BA) 11800 10226 3492 93 
H(7BA) 9340 7683 2316 95 
H(9BA) 7779 7472 3063 110 
H(10B) 6872 7861 4368 92 
H(11B) 11439 7274 2020 52 
H(13D) 12736 9171 2630 111 
H(13E) 12190 10642 2039 111 
H(13F) 12721 9096 1580 111 
H(14D) 7308 10042 6890 128 
H(14E) 8068 11096 6319 128 
H(14F) 8413 9270 6668 128 
H(1S1) 6988 10131 2446 88 
H(1S2) 6133 9296 1742 88 
H(1S3) 6334 11273 1725 88 
H(2S1) 879 9205 7299 79 
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Table B.4. Continued. 
______________________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________________  
H(2S2) -26 7938 6921 79 
H(2S3) 1024 7235 7457 79 
H(3S1) 6980 9739 9260 96 
H(3S2) 7347 7994 8873 96 
H(3S3) 7679 9717 8440 96 
H(1SO) 7388 8846 1102 56 
H(2SO) -210 7368 8394 56 


































































































































































Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y+1,z-1    #2 -x+1,y-1/2,-z+1    #3 x,y-1,z       
#4 x-1,y-1,z+1    #5 x-1,y-1,z    #6 x-1,y,z+1       
#7 -x+1,y+1/2,-z+1    #8 -x+2,y-1/2,-z    #9 x,y-1,z-1       
#10 x+1,y,z-1    #11 -x+2,y+1/2,-z    #12 x,y+1,z       
#13 x,y+1,z+1    #14 x+1,y+1,z       
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TableB.6. Hydrogen bonds for methanol solvated form of sodium naproxen [Å and °]. 
______________________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
______________________________________________________________________________________  
 O(1S)-H(1SO)...O(2)#7 0.91 1.89 2.731(5) 152.0 
 O(2S)-H(2SO)...O(2B)#2 0.87 1.82 2.670(5) 163.3 
______________________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y+1,z-1    #2 -x+1,y-1/2,-z+1    #3 x,y-1,z       
#4 x-1,y-1,z+1    #5 x-1,y-1,z    #6 x-1,y,z+1       
#7 -x+1,y+1/2,-z+1    #8 -x+2,y-1/2,-z    #9 x,y-1,z-1       
#10 x+1,y,z-1    #11 -x+2,y+1/2,-z    #12 x,y+1,z       
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